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Abstract 
Fibroblast growth factor receptor plays a major role in several biological processes. Without FGFR, a 
human cannot live. FGFR is involved in cell differentiation and wound healing. Of course, if FGFR 
signaling becomes unregulated, it causes severe distress in the body. Several cancers are contributed to 
high signaling levels, as well as developmental conditions like rickets and Kallmann’s syndrome. FGFR 
is thought to undergo an auto-inhibition (or self-regulatory) process in order to try to facilitate regulation. 
The exact method of this inhibition is currently unknown, but is proposed to involve the unstructured acid 
box region of FGFR. We developed a simple model system in order to further investigate current models 
of inhibition that FGFR may undergo. By using our model system, which contains two 15-mer 
homopolypeptides of polyE and polyK that mimic the acid box region and its binding site respectively, 
we were able to use a combination of ITC, CD, NMR, and FRET to show that one model from the 
literature contains flaws. We are able to characterize the binding of our polypeptide system under varying 
ionic conditions and pH. This model system also provides a platform to better understand general 
principles of charge-charge interactions in proteins, which are often characterized by FRET. One of the 
important findings from this study is that 15-mers of polyE and polyK bind in a parallel arrangement. One 
of the hurdles in applying FRET to such systems is determining the role that the attached FRET dyes play 
in the charge-charge interactions. Our model system allowed us to use the preference of the charged 
polypeptides to bind in a parallel arrangement to determine the size, charge and structural effects of the 
attached FRET dyes on how peptides bind under electrostatic interaction conditions and to quantify how 
the attached fluorescent dyes are quenched by both the charged amino acids as well as by the FRET 
acceptor. 
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1.1 Protein Makeup and Structure 
All biological lifeforms consist of proteins
1
. Even though the number, size, and shape of 
proteins are limitless, all are made up from the same 20 amino acids. Each amino acid has its 
own characteristics which contribute to the protein’s structure and/or function. The various side 
chains on the amino acids determine how the protein will fold based upon the charge and 
hydrophobicity of the functional group of the amino acid
2
. Out of the 20 total amino acids, there 
are 4 that have a charge at physical pH, 7.2. This small percentage of charged amino acids 
represents the need to regulate the total charge of a protein. Too many charges would hinder a 
protein from folding to a compact structure
3
, which many need to perform their function. The 
overall structure of a protein determines its function and where in the cell the protein will be 
located. Not all proteins fold the same way, with some proteins having a loose, flexible structure 
while others are rigid. It has long been thought that the structure of a protein determined its 
function
4
 until relativity recently, even though this is still true for most proteins.  Most proteins 
function by binding to other proteins or small molecules inside of the cell. This binding can 
occur by a variety of means including, but not limited to, oppositely charged (electrostatic) 
interactions, hydrogen bonding and hydrophobic forces. When a ligand binds to a protein, the 
protein will often slightly change its structure to enable the ligand to bind more tightly or to 
facilitate another ligand to bind
5
. Often, the structure of the ligand will match that of the protein 
that it is designed to bind – the lock-and-key mechanism
6
. If binding occurs through opposite 
charges (electrostatic interactions), the ligand and protein will have surface-charge 
complementarity, which means that the protein will have a pocket of negatively charged amino 




1.2 Intrinsically Disordered Proteins  
Many of the molecular targets for protein binding are not shape determined, as some 
proteins are intrinsically disordered. This type of disorder can mean that the protein does not 
have specific secondary structural elements such as alpha helices or beta sheets that often 
contribute to protein shape. It can even mean that the protein has no shape whatsoever. 
Intrinsically disordered proteins (IDP’s) make up roughly 33% of the known proteins today in 
eukaryotic systems
7
. Though once thought to have no function
8
, several very important roles 
have been found to be performed by IDP’s
9
. There is evidence for their participation in cell 
signaling and transcription factors
10
, as well as having been connected to several important 
diseases such as Alzheimer’s and cancer
11
.   Intrinsically disordered proteins or peptides 
generally contain a high number of charged amino acids
12
, and most of their function arises from 
the polarity of charges of their amino acids as well as their sequence/density. There are different 
binding/folding models for IDP’s that are thought to drive the binding process. One such model 
is the “fly-casting” mechanism. This particular mechanism uses the fact that the IDP is initially 
unfolded and elongated, containing a high degree of entropy. With the high density of charged 
residues, the protein is able to use long-range electrostatic forces to “feel” around for its binding 
partner. Once bound weakly through these electrostatic interactions, the protein can begin to 
form a more specific structure and bind more tightly to its partner
13
. This model accounts for the 
observation of fast binding kinetics and takes into account the extreme flexibility of unfolded 
proteins
14
.  A second model recognizes that some IDP’s never fold, even after binding. Termed 
the “fuzzy complex” mechanism, the IDP stays unfolded after binding to an ordered protein
15
. A 
typical example of an IDP binding to a structured protein is the p53 protein binding to MDM2. 
p53 is a mostly disordered protein that is involved in tumor suppression. MDM2 is a globular 
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protein that negatively regulates p53. p53 binds to MDM2 through one of the disordered regions 
on p53, mainly through hydrophobic and aromatic residues. Once bound, this disordered region 
then adopts a helical coil structure
16
. This protein, like many others, was initially thought to not 
have a function for the disordered region, since there are ordered regions that were known to be 
involved in DNA binding. Some proteins bind through charge-charge interactions only though. 
An example of this includes the Sac10b family that binds to DNA
17
. This family is made up of 
small proteins that bind to DNA with no sequence specificity. These proteins protect the DNA 
from digestion by Dnase I. This family of proteins is highly conserved and contains 3 pairs of 
positively charged residues that bind to DNA. When these amino acids are changed to uncharged 
residues, the protein cannot bind to DNA. 
1.3 Electrostatic Interactions 
One of the primary binding mechanisms of proteins is through charge-charge interactions 
from electrostatic forces. Coulomb’s law tells us how strong electrostatic interactions are based 
upon distance by the formula: F = k q1 q2 / r
2
 where F is the force, q 1and 2 are electric charges, r 
is distance, and k is proportionality constant. This information is very helpful when determining 
how neighboring charges affect each other when a protein is folding or when a ligand is trying to 
bind since like charges repel each other while opposite charges attract. A large percentage of 
proteins have charged amino acids in their binding pockets that facilitate the binding of their 
partner. The lock-and-key binding model
18
 is the most common binding model for folded 
proteins that have complementary shapes and charges. However, when there is no structural 
complementarity between partners, the charges themselves must be the leading factor for getting 
proteins to bind to ligands or other molecules.  The electrostatic interactions between the protein 
and ligand are the only aspect that can contribute to binding other than hydrogen bonds which 
are substantially weaker. Coulomb’s law tells us that opposite charges attract each other, and at 
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what distances these charges can be recognized by other molecules but not much information has 
been acquired about how the surface-charge complementarity
19
 and the binding affinity of 
protein targets relate. It is also unknown how the peptides with highly charged residues orient 
themselves and how do the proteins find their partner and not just bind to everything charged 
they come across. 
1.4 Fibroblast Growth Factor Receptor 
One particular interesting example for a protein with a functionally-important, as well as 
potentially being cancer-related, intrinsically disordered region is the fibroblast growth factor 
receptor (FGFR). FGFR’s are known to play a role in wound healing, cell growth, and new blood 
vessel growth (angiogenesis) among many other biological processes
20
. On the other hand, 







, and pancreatic cancers
27, 28
. Mutations of the FGFR protein can also 
cause cancer by changing the activation of pathways that stimulate tumor growth
29
. There are 4 
known FGFRs, each consisting of 3 immunoglobulin-like domains (D1, D2 and D3), an acid box 
(AB) region linking D1 and D2, a transmembrane domain that follows D3, followed by a 
cytoplasmic tyrosine kinase domain
30
.  The AB region is an intrinsically disordered region, and 
is thus very flexible. It gets its name from the high percentage of acidic residues found there; 
nearly 50% of the amino acids are acidic, and are negatively charged at physiological pH
31
.  The 
amino acid sequence of the acid box of FGFR2 is shown in figure 1.1. 
                                                    
Figure 1.1. The amino acid sequence of the FGFR2 acid box. The charged residues are 
highlighted in red. The high percentage of charged residues makes this protein region one of 
interest. The charged residues are potentially involved in binding to a ligand binding site on a 






The two main binding partners for FGFR are FGF and heparin; their binding sites are on 
the D2 domain with a small portion of the FGF interacting with the D3 domain. There are 2 
exons that code for the last half of the D3 domain in most FGFR’s that can cause two different 
isoforms of the receptor
32
. One variant is expressed in epithelial tissue while the other is found in 
mesenchymal tissue
33
. This alternative splicing changes the specificity of the receptor to 
different FGF proteins that have been identified
34
. Most published structures of FGFRs consist 
only of the D2 and D3 regions in a dimeric complex with its FGF and heparin partners (figure 
1.2). Currently there are no crystal structures for FGFR  that have been determined in the 
absence of ligand
35
. Not having an uncomplexed structure available makes it very difficult to get 
mechanistic information about the protein. 
 
Figure 1.2. FGFR/heparin complex. A) View from the side of the complex. FGFR2 domains 
D2 and D3 are cyan and magenta, respectively, and FGF1 is green. The heparin molecule is 




 1.5 Fibroblast Growth Factors 
Fibroblast growth factors (FGF’s) were the first known angiogenic factors
37, 38
.  There are 
22 known human FGF’s 
39
, with these proteins being found in both vertebrates and invertebrates. 
The FGF genes are widespread throughout the human genome and are located on several 
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different chromosomes. FGFs can be divided into subgroups with each subgroup having a high 
percentage of sequence similarity and developmental properties. The range of molecular weights 
for human FGFs is between 17 and 34kDa. There is a highly conserved core region that contains 
28 homologous amino acids, of which 6 are identical
20
. Ten of the core amino acids interact 
directly with FGFR
40
. The mammalian FGFs are expressed in almost all tissues but in different 
patterns and at different times
41
. FGFs are glycoproteins that are found in the extracellular matrix 
and on the cell surface. In order for them to be used in signaling, they first have to be released 
into the extracellular matrix to be exposed to the cell surface, where they bind to heparin  and the 
membrane-bound receptor 
42
. Once the FGF is bound to the receptor, dimerization occurs. At this 
point it is thought that heparin sulfate glycosaminoglycan binds to a specific site on the dimer, 
although there is still debate on exactly when heparin binds. Some researchers propose that the 
heparin binds to FGF before it binds to the receptor, thereby stabilizing the protein against 
degradation 
43
. In any case, the formation of the dimer causes a conformational change that 
activates the tyrosine kinase domain which results in it becoming phosphorylated. This 
phosphorylated residue acts as a docking area when the FGFR interacts with other proteins, 
which starts a signaling cascade consisting of multiple pathways. FGF receptors are also 
involved in negative feedback regulations, though not much about the mechanism is known, 
except that the receptor is degraded. Fibroblast growth factors undergo auto-regulation to 
balance cell growth and death to maintain a healthy state. When the regulation breaks down, 







. Overexpression of some FGFR’s has been shown to produce tumors but it 
is not clear whether it is because the higher amounts of FGF receptor binds more ligands to result 





1.6 Fibroblast Growth Factor Receptor Signaling and Regulation 
FGFR is involved in several different signaling pathways including RAS/MAPK and PI-3 
kinase/Akt (figure 1.3). The signaling for this receptor starts when FGF and heparin or heparin 
sulfate bind to the extracellular domains, D2 and D3, on FGFR causing receptor dimerization 
and activation that causes the tyrosine kinase domain to auto-phosphorylate. Signaling proteins 
such as STAT1, Gab1, and FRS2α are then phosphorylated so they can begin their roles in cell 
differentiation, cell survival, and cell proliferation
20
. Regulation for FGFR involves pericellular 
matrix heparin sulfate. This small molecule controls the FGFR signaling on many levels
47
 and 
when it’s not available, the complex cannot be activated. Regulation can also come from the 
different isoforms of the receptor. Natural splicing can change the D3 domain but it may also 
remove the first domain (D1) and AB region. Both of these changes can cause the binding 
affinity of FGF for the receptor to change by either increasing or decreasing the affinity of the 
FGF for the receptor. For example, when the D1 and AB regions are removed from the receptor, 
binding affinity increases between FGFR and FGF but in some isoforms where the D3 domain is 
changed, the binding affinity of FGF1 to FGFR is greatly reduced
48
. FGFR is also thought to 
undergo self-regulation by auto inhibition
49
. There are two competing theories surrounding the 
auto inhibition or self-regulation of FGFR. In both cases, inhibition results in a reduction in the 
receptors’ affinity for FGF
48
.  One method proposes that FGFR undergoes auto inhibition by the 
flexible acid box region swinging down and binding to the heparin binding site on the D2 
domain (figure 1.4 A) 
49-51
.  The rationale for this hypothesis is that the acid box region is highly 
negatively charged while the heparin binding site in D2 is highly positively charged. Kalinina et 
al have recently supported this hypothesis using NMR to determine which residues are perturbed 
when the AB region of the protein is deleted versus when it is present
51
. Olsen et al. have shown 
using Surface Plasmon Resonance that the presence of the D1 domain decreases the binding 
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affinity of heparin to an FGFR
49
, which was subsequently reproduced and extended by Kalinina 
et al
51
. The competing hypothesis suggests that the acid box region binds to FGF instead of 




Figure 1.3. Signaling pathway for FGF. Four of the pathways that are set in motion by the 
phosphorylation of FGFR
53
. The yellow box represents the inside of the cell. The top left part of 
the figure shows FGFR bound to heparin sulfate, FGF, as well as 3 signaling proteins: FRS2, 
JAK, and PLCγ. The various pathways are shown that occur once the dimerization and 




Figure 1.4. Proposed model for auto inhibition of FGFR.A) The acid box binds to the heparin 
binding site of the D2 domain. B) FGF binds to the acid box and blocks the FGF binding site on 







1.7 Charged Homopolypeptides as a Model for Charge Complementarity 
Homopolypeptides are constructed of a single type of amino acid repeated any number of 
times. Homopolypeptides were used in the late 1960’s and 1970’s to study the stability of side 
chain conformations,
54-56
 often by analyzing the Raman spectroscopic peaks caused by secondary 
structure formation 
57, 58
. At that time, it was well known that long chains of glutamic acid would 
form a random coil at pH 7 but could be forced into either an alpha helix by lowering the pH to 
4, or a beta sheet by adding long chains of poly lysine. Poly lysine itself is a random coil at pH 7 
and is alpha helical at pH 11
59
. Long chains of glutamic acid with long chains of lysine were 
later used as films that helped to preserve the structure of DNA
60, 61
. The size of the polypeptide 
chains used in previous studies have always been long (<100 amino acids). Recently shorter, 
more relevant homopeptides have been the focus of study. For example, by using a peptide of 34 
arginine residues, the effect of the net charge per residue on the globule to coil transition was 
examined by replacing various arginine residues with other amino acids
62
. This study concluded 
that a higher average charge per residue did increase the amount of coiled structure of peptides.  
However, shorter, more biologically relevant versions of homopolypeptides – in terms of sizes 
relevant to protein regions of interest, such as the acid box of FGFR described above – have not 
been extensively studied. The binding between these unstructured, oppositely charged peptides 
arises from electrostatic interactions. Homopolypeptides constructed of glutamic acids and lysine 
are excellent subjects for binding interaction studies as they have charge complementarity and 
are largely disordered at neutral pH
55
, they are also a good model for our possible acid 
box/heparin binding site study since the major amino acid in the acid box is glutamic acid and 
the possible binding site on the D2 domain consists of a positive region of residues. We will be 
able to get an idea if the acid box/heparin binding site theory is practical based upon the amount 
of binding in our model system. 
11 
 
1.8 Fluorescence and Quenching 
Fluorescence is the emission of light from the excited state of a molecule (figure 1.5). 
This emission occurs in usable timeframes and can be measured by simple machines.  Quenching 
occurs when the intensity of fluorescence is decreased or diminished altogether
63
. Quenching can 
occur through wanted as well as unwanted means. Collisional quenching occurs after collisions 
of the fluorophore with another molecule that causes the excited electron to return to its ground 





Figure 1.5. Jablonski diagram for fluorescence. When an electron in the ground state is 
excited, it moves into an excited singlet state (absorption). This electron can then return to the 






1.9 Fluorescence Resonance Energy Transfer 
One use of fluorescence is in the technique of fluorescence resonance energy transfer 
(FRET). In FRET, there is one fluorescent molecule (termed the donor) and another molecule 
(termed the acceptor) that can accept the energy of the first molecule. FRET occurs by the donor 
molecule being excited by an external source and becoming fluorescent. At distances unique to 
the donor molecule but always less than 100 Å, the donor can transfer its energy to the acceptor. 
This transfer of energy causes the donors’ fluorescent signal to decrease. If the acceptor 
molecule is also fluorescent, then the acceptor will fluoresce once the energy has been 
transferred (figure 1.6). It should be noted that the fluorescence of the donor is not transferred to 
the acceptor, only the energy is transferred. The donors’ fluorescence will decrease when the 
energy is transferred according to the amount of energy transferred.  The energy transfer process 
is dependent upon several factors including distance between dye molecules (figure 1.7) and the 
overlap of the donor’s emission spectrum with the acceptors absorption spectrum (figure 1.8). 
The amount of overlap of the two spectra will determine how much energy is transferred at a 







is the distance between the donor and acceptor molecules and R0 is the Forster distance. The 
Forster distance is the distance at which the energy transfer is 50%, figure 1.7. This factor is 
determined by the quantum yield (Q0) of the donor in the absence of the acceptor, the orientation 
of the dipole (κ
2
) of the molecules, as well as the refractive index (η) of the medium in which the 
molecules are in and the integral of the spectral overlap (J). The equation for Forster distance is  
R0
6
 = (9000 Q0 (ln10) κ
2




NA where NA is Avogadro’s number. The Forster distance 
is comparable to that of a biological macromolecules, since it is in the range of 20-100 Å. 
Because of the strong distance dependence of FRET, this technique gives researchers the ability 
to measure intra- and inter-molecular changes in proteins, DNA molecules, ion channels, and 
13 
 
many other biological molecules/systems that have structural or interactional changes. Some of 
the uses for FRET include determination of structural characteristics of intrinsically disordered 
proteins
66
, monitoring kinesin motor proteins
67
, and measuring the electrostatic repulsion 
between the domains of calmodulin
68
. This is such a useful tool for analysis because it allows for 
varying temperatures and ionic concentrations and, importantly, does not use large amounts of 
sample. This technique is extremely sensitive and facilitates the use of very low concentrations 
of sample by employing fluorescent dyes as labels on the amino acid residues of proteins or 
peptides. By careful placement of the fluorescent dyes, the relative orientation of binding 
partners can be elucidated. 
 
 
Figure 1.6. FRET occurs through energy transfer. A) The donor (green) and acceptor (red) 
molecules are close together so the donor’s energy is transferred to the acceptor. The donor is no 
longer fluorescent but the acceptor is. B) The donor and acceptor are too far apart for energy 







Figure 1.7. Distance dependence of energy transfer. The energy transfer efficiency varies for 







Figure 1.8. Spectral overlap for donor and acceptor needed for FRET. On the left side we 







1.10 Fluorescent Dyes 
Fluorescent dyes come in a myriad of structures, sizes, and charges. There are several 
properties of fluorescent dyes that are important when determining which ones to use, with the 
most commonly considered ones being the wavelength of light that will be used and the quantum 
yield of emission. The environment that the dye will be used in is also paramount. There are 
some dyes that are designed to be used in vivo, namely near infrared fluorochromophores, while 
others are strictly for in vitro like rhodamines. When measuring electrostatic interactions, the 
charges of the dyes themselves should be taken into consideration, as well as the size of the dye, 
especially if they will be placed close to the binding site. One property of fluorescent dyes that is 
not normally but can be beneficial is fluorescence quenching.  As we have seen, FRET is one 
method of controlled quenching that we can use for measurements. Other types of quenching like 
collisional and static quenching by environmental factors or other molecules in the solution are 
not always welcome. When quenching occurs by a method other than the one being studied then 
it is a hindrance. Most commercially available fluorescent dyes are stable and are thought to 
resist minor environmental changes. Though fluorescent dyes have been used for many years, the 
effects of the dyes on the measured values collected in FRET studies have not been studied 
explicitly. We chose a system of two highly charged homopolypeptides that bind through 
electrostatic interactions to measure the effects of the charges of the peptides on the fluorescence 
of the dyes as well as the charges of the dyes on the binding of the peptides. By using multiple 
dyes with various charges, we were able to determine the effects the peptide charges have on the 
dyes, such as decrease in quantum yield, with no other possible contributions from factors 
outside of our system like other proteins or molecules in solution.
16 
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II. Thermodynamic and Structural Characterization of Interactions between Oppositely-Charged 
Short-Chain Homopolypeptides 
 
Ashley Howard, Nicole Webb, T.K.S. Kumar and Colin D. Heyes 
2.1. Abstract 
Interactions between charged amino acid residues have long been recognized as important in a 
variety of intra- and inter- protein interactions. The prevalence of disordered regions in proteins 
on the order of ~15 amino acids with high acidic or basic amino acid content has drawn recent 
attention due to a general shifting in the paradigm of the structure-function relationship in 
proteins and the connection of intrinsic disordered proteins (IDPs) with various diseases. In this 
study, we undertake a systematic characterization of the thermodynamic and structural properties 
underlying 15-mers of poly-K and poly-E under various conditions of pH, ionic strength and 
solvent hydrophobicity. We found that, after interaction, oppositely-charged homopolypeptides 
of this length remain as random coils at neutral pH in aqueous solutions with the interaction 
being endothermic and strongly entropy driven. Increasing ionic strength does decrease their 
affinity but does not change the sign of ΔS or ΔH. However, in more hydrophobic solvents the 
sign of ΔH of interaction does change to an exothermic interaction. Moreover, the interacting 
homopolypeptides showed secondary structure (β-sheet) in environments of much lower 
hydrophobicity compared to the individual non-interacting homopolypeptides. 2-D NMR showed 
that interaction occurred primarily via the side-groups with very little interaction between the 
backbone amide groups. Furthermore, we found that there is a strong preference for the 
polypeptide chains to bind in a parallel arrangement with the C-termini and N-termini aligned 
with each other. We anticipate that these results will help improve our understanding of how 





Charged amino acids play a number of important roles in protein chemistry, including 
protein stability, folding, ligand binding, and protein-protein interactions and are central to 
function in intrinsically disordered proteins (IDP’s) 
1-7
. IDPs have not only been linked to 
important biological processes 
8-12
 but also been implicated in several diseases 
13, 14
. However, 
much less is known about the structure-function relationship of IDPs compared to structured 
proteins. A key feature of IDPs are that they contain a relatively large content of charged amino 
acids 
15
, with some regions containing up to ~15 residues with almost 100% charged 
composition 
16
. Analyses of electrostatic interactions using continuum electrostatics models have 
highlighted the importance of electrostatic complementarity in protein, peptide and nucleotide 
binding 
17
. For example, longer arginine-rich peptides were found to bind to SiRNA more rapidly 
than shorter peptides 
18
.  In general, binding of IDPs’ to their molecular targets is characterized  
by high-specificity and low-affinity 
19
. However, this description has been recently questioned in 
the context of relating flexibility and complementarity 
20
. In this setting, it is important to 
understand the relationship between electrostatic surface complementarity and binding affinity of 
a protein/peptide to its molecular target(s) to better understand the interplay of structural forces 
governing the binding specificity in IDPs.    
It is also known that electrostatic interactions play an important role in the folding of 
proteins and peptides 
1, 21, 22
. Computational studies on the folding of small and medium-sized 
polypeptides have shown that folding thermodynamics and kinetics depend strongly on the 
length of the peptide 
23
. Furthermore, protein misfolding is becoming an important focus due to 
the link between several diseases with misfolded proteins. For example, it is known that tau and 





Moreover, there is often not a clear distinction between IDPs and misfolded proteins, 
complicated by the fact that disorder is often a precursor to misfolding, and some of the same 
diseases are associated with both IDPs and misfolded, structured proteins; Alzheimer’s disease 
being an important example 
25, 26
. Naturally, electrostatic interactions are expected to play 
important roles in these proteins and associated diseases. Such interactions can be long range but 
are distance and ionic-strength dependent, so factors such as protein and salt concentrations as 
well as pH are expected to play important roles, and much work is still needed to quantify them. 
In the current study, two oppositely-charged homopolypeptides are used as a model for 
electrostatic-mediated protein binding. The homopolypeptides selected were 15-mers of poly-L-
glutamic acid (polyE) and poly-L-lysine (polyK). While the biophysics of much larger versions 
(>80 amino acids) of these peptides have been well-studied under various conditions, shorter 
peptides, which are much more relevant to protein interactions, lack similar fundamental 
biophysical studies. Long chains of polyK exhibit random coil structures at neutral and acidic pH 
but are known to form  α-helix structures in basic solutions, which can be transformed into β 
sheets by gently heating 
27
. This polypeptide also adopts a α-helical structure in polar organic 
solvents such as acetonitrile 
28
 and trifluoroethanol (TFE) 
29
. Long chain polyE is a random coil 
at neutral and basic pH, a α-helix at acidic pH and can also transition into a β sheet when heated 
30
. It is still unknown, however, how short versions of these polypeptides behave when titrated 
together. Understanding the relationship between interaction thermodynamics and structure that 
underlies specificity for complementary charged regions of proteins on the order of ~15 residues 
is expected to provide valuable information on the structural forces that govern electrostatic 
interactions in both structured and unstructured proteins. The interaction thermodynamics 
between these homopolypeptides were studied using isothermal titration calorimetry (ITC) and 
25 
 
fluorescence resonance energy transfer (FRET) and the effects of the interactions on the 
structural properties were studied using circular dichroism (CD) and nuclear magnetic resonance 
(NMR) spectroscopy. FRET showed that the C terminus of polyK interacts with the C terminus 
of polyE in a parallel arrangement. The interaction strength was found to depend strongly on the 
pH and ionic strength of the aqueous solution. Interestingly, after binding, the polypeptides 
remained largely as a random coil in neutral pH aqueous solutions although they showed some α-
helical character in acidic or basic conditions. However, they formed β sheet secondary 
structures when they interacted in TFE.  This is in contrast to much longer versions of these 
peptides, which were found to form β-pleated sheets in acidic or neutral aqueous solution, did 
not interact in basic aqueous solutions and formed aggregates in less-polar solvents, which were 
suggested to be α-helical structures 
31
. We were able to determine that electrostatic interactions 
between side-chain groups plays a major role in the binding of these highly charged 
homopolypeptides in aqueous solutions but in more hydrophobic environments (high TFE 
concentration), hydrogen bonding interactions with backbone C=O and N-H groups play a 
stronger role causing large secondary structural changes within the homopolypeptides.  
2.3. Materials and Methods 
2.3.1. Peptide Synthesis and Labeling 
The far UV CD, NMR, and ITC experiments were carried out using 15-amino acid long 
homopolypeptides (polyE and polyK) synthesized on a Perkins Elmer/ Applied Biosystems 
433A synthesizer using “FastMoc” chemistry 
32
. The molecular mass of the homopolypeptides 
were verified by ESI mass spectrometry. For fluorescence-based  experiments, peptides with the 
sequence E15C, E6CE9 and K14CK were ordered from Genscript to enable site-specific labeling 
using maleimide chemistry 
33
. E15C or E6CE9 was labeled with the donor dye Alexa Fluor 488 
(labeled polyE) and K14CK was labeled with the acceptor dye Atto 633 (labeled polyK). 
26 
 
Labeling was carried out using a 5:1 ratio of dye to peptide in 10 mM phosphate buffer at pH 
7.2. The mixture of peptide and dye, protected from light, were allowed to react overnight. The 
unreacted free dye was separated out by dialysis using 2 kDa molecular weight cut-off dialysis 
tubing (Spectrum Labs). The samples were dialyzed against 10 mM phosphate buffer for 24-48 
hours with the external buffer being refreshed every 2-6 hours. The labeling efficiency was 
verified by MALDI mass spectrometry (Bruker Ultraflex II TOF/TOF time-of-flight mass 
spectrometer equipped with a MALDI ion source (Bruker Daltonik GmbH, Bremen, Germany)). 
2.3.2. Circular Dichroism  
Far UV circular dichroism experiments were performed using a Jasco J720 
spectropolarimeter.  Homopolypeptide (polyE and polyK) solutions were prepared in deionized 
water.  The final pH of the homopolypeptide solutions were carefully adjusted either using 1 M 
HCl or 1 M NaOH.  A 1:1 equimolar mixture of the homopolypeptides was prepared by mixing 
100 L of 1 mM polyK, at room temperature, with 100 L of polyE.  The desired pH of the 
mixture was adjusted using HCl and NaOH, the pH meter was equipped with a microprobe.  
Titration experiments with 2, 2, 2, trifluoroethanol (TFE) were carried out by mixing a 1:1 
mixture of polyK and polyE with appropriate volumes of clean TFE.  The resultant mixture was 
readjusted to the desired pH.   All far UV (190 nm – 250 nm) CD spectra were acquired, at room 
temperature, using a 1 mm path length quartz cell.  CD spectra were collected using a band width 
of 1 nm and a scan speed of 50 nm/second and appropriate blank corrections were made in all 
spectra.  
2.3.3. Isothermal Titration Calorimetry  
All isothermal titration calorimetry experiments were performed at room temperature 
using VP-ITC (Micocal Inc.).  1 mM solution of polyK, placed in the reaction cell, was titrated 
incrementally (in 6 L aliquots) with 10 mM solution of polyE (placed in the injecting syringe) 
27 
 
with a 12 second interval between injections. The heats of the reaction per injection 
(microcalories/second) were determined by integration of the peak areas using the Origin 
software (version 7.0).  The thermodynamic and binding stoichiometry values, characterizing the 
interaction(s), were calculated by fitting the raw data using the fitting models provided in the 
software.  The best-fit of the data was judged based on the 2 values obtained on the individual 
fits.   
2.3.4. Nuclear Magnetic Resonance (NMR) Spectroscopy 
NMR data were acquired at 25 C on a Bruker AVANCE 700 MHz spectrometer 
equipped with a 5-mm triple resonance cryoprobe. 1 mM homopolypeptide (polyK and polyE) 
solution was prepared in 5% v/v D2O + 95% v/v H2O. The final pHs of the solution(s) were 
adjusted with either 1 M HCl or 1 M NaOH.  Two-dimensional proton TOCSY and NOESY data 
were acquired with 2048 data points in the F2 dimension and 512 increments in the F1 
dimension. The spectral width was set to 12 ppm. TOCSY and NOESY spectra were acquired 
with mixing times of 60 ms and 150 ms. NOE-based distance restraints were derived from 2D 
1
H 
NOESY data obtained using different (200, 250, 300, and 350 ms) times. NMR spectra were 
processed using XWIN-NMR and Sparky software 
34
.  
2.3.5. Fluorescence Resonance Energy Transfer (FRET) Spectroscopy  
FRET measurements were made on a PTI Quantamaster 40. The concentration of labeled 
polyE was set at 5.0 × 10
-8 
M. The concentration of labeled polyK varied from 5.0 × 10
-10
 to 1.5 
× 10
-6 
M. The sample was excited at 470 nm and emission data were collected from 480 nm to 
750 nm. The transfer efficiency was calculated by using the relative fluorescence intensity of the 
donor at 516 nm in the presence (FDA) and absence (FD) of the acceptor 
35
 using: E= 1 – 





2.4. Results and Discussion 
2.4.1 Peptide Selection, Labeling and Characterization.  
Cysteine residues were introduced in polyE either as the C-terminal most amino acid 
(E15C) or in the middle of the peptide at position 7 (E6CE9) to examine the binding efficiency 
and also probe the relative orientation of the interacting homopolypeptides.  However, 
introduction of a cysteine residue in polyK as the C-terminal most amino acid proved to be 
technically challenging and therefore the cysteine was introduced as the penultimate residue 
from the C-terminal end of polyK (K14CK). 
The molecular mass and the location of the cysteine group were confirmed by MS/MS 
data (figure 2.1) on the homopolypeptides. PolyE (E15C and E6CE9) and polyK (K14CK) were 
tagged with fluorescent dyes Alexa 488 and Atto 633, respectively.  MALDI mass analysis of the 
purified florescent labeled homopolypeptides showed the expected molecular mass and verified 





Figure 2.1. MS/MS of E15C, E6CE9 and K14CK.  Top panel  is for E15C, middle is E6CE9, 
bottom is K14CK. These results show the various fragments (labeled B2 through B15) that 





Figure 2.2. MALDI-TOF MS of labeled peptides after purification.  MALDI shows a single 




2.4.2. Isothermal titration calorimetry (ITC) of polyE/polyK Binding 




, and the enthalpy and entropy changes 
41, 42
 governing interactions. The interaction between 
polyE and polyK under different conditions of pH (pH – 2.0, 7.0 and 13.0) and salt 
concentrations (100 mM, 250 mM, and 500 mM NaCl) was examined using ITC (figure 2.3).  
 
 
Figure 2.3. ITC data for polyE/polyK binding in A) pH2, 0 mM NaCl; B) pH7, 0 mM NaCl; 
C) pH13, 0 mM NaCl; D) pH7, 100 mM NaCl; E) pH7, 250 mM NaCl; F) pH7, 500 mM NaCl. 
From N. Webb, Conformational Studies of Homopolypeptides.  
 
Both polyK and polyE are charged at pH 7.0. The binding between the oppositely-
charged homopolypeptides, at pH 7.0, is endothermic and proceeds with an overall increase in 
32 
 
entropy.  The binding isotherm is biphasic and best fits to a two–site binding model. The binding 
occurs with an average binding constant (KD(app)) of 1.21 x 10
-8 
M (Table-2.1). The two observed 
phases plausibly represent two discrete steps involved in the binding between the two oppositely 
charged homopolypeptides. This suggests complex electrostatic interactions in which the 
charged homopolypeptides interact differently at high concentrations than at low concentrations 
in low ionic strength conditions, possibly via some cooperative aggregation process. The average 
binding affinity between polyE and polyK at the extremes of pH (pH 2.0 and 13.0), wherein one 
of the polypeptides is not charged, is reduced by 4-5 orders of magnitude to 5.75 × 10
-3
 M and 
4.71 × 10
-4 
M, respectively.  For binding interactions between the homopolypeptides at pH 2.0 
and pH 13.0, the affinities are much weaker and so saturation was not observed, leading to 
accurate values for the enthalpy and entropy of these interactions not being able to be quantified. 
However, the sign of the enthalpy change is clear from the direction of change of the peaks 
during titration. Interestingly, unlike at pH 7, binding interactions between the homopolypeptides 
at pH 2.0 and pH 13.0 are exothermic.  
Table 2.1. Thermodynamic parameters describing binding of polyE to polyK under various 
conditions of pH and NaCl concentration as measured by ITC.  From N. Webb, 
Conformational Studies of Homopolypeptides. 







pH 2, 0 mM NaCl 5.75 × 10
-3
 N/D (-ve) N/D 
pH 13, 0 mM NaCl 4.71 × 10
-4
 N/D (-ve) N/D 
pH 7, 0 mM NaCl 1.21 × 10
-8
 7.2 50.8 
pH 7, 100 mM NaCl 1.07 × 10
-7
 4.5 47 
pH 7, 250 mM NaCl 9.0 × 10
-7




ITC data were acquired at pH 7.0, as a function of ionic strength (0 mM to 500 mM 
NaCl) to determine the nature of forces which are in play in the interaction between polyE and 
polyK (figure 2.3 B,D,E,F). The binding affinity of the charged homopolypeptides was very 
strong in the absence of salt (KD = 1.21 x 10
-8 
M). A progressive loss in binding affinity was 
observed as the NaCl concentration was increased from 100 mM to 250 mM (figure 2.3 B,D,E,F) 
The binding between the charged homopolypeptides was almost completely abolished at 500 
mM. It should be noted that the ΔH and ΔS values are all positive at pH 7 and they are seen to 
increase with increasing NaCl concentration.  
In general, the decrease in binding affinity upon increasing the ionic strength suggests 
that the interaction between the charged homopolypeptides, at neutral pH, is predominantly 
electrostatic. The observed of lack of binding at 500 mM NaCl, even though at 250 mM the 
binding is still relatively strong coupled with the weak but clear binding at pH 2 and pH 13 
suggests that the binding mechanism is complex. While the ΔH changes to negative as the ionic 
state of either polypeptide is changed through pH, these ΔH values remain positive as you 
increase the NaCl concentration at pH7. All of this information together highlights this 
mechanistic complexity and suggests that structural changes upon binding are different under the 
different pH and NaCl conditions.  
2.4.3. polyE/polyK Binding Studied by FRET 
 Fluorescence techniques have extremely high sensitivity, allowing for significantly lower 
concentrations than are used in ITC. Moreover, due to the strong distance dependence of FRET, 
careful placement of the dyes can provide information on the relative orientation of the 
interacting homopolypeptides. By labeling polyE with the donor dye (Alexa 488), we were able 
to measure the decrease in its signal when the acceptor-labeled polyK (Atto 633) was titrated 
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into the solution. We used the same NaCl concentrations as for ITC, 0 mM to 250 mM NaCl. 
Figure 2.4 shows the FRET data for the donor-labeled E6CE9 (figure 2.4A) and E15C (figure 
2.4B) samples upon adding acceptor-labeled K14CK polypeptide. When the donor dye was 
placed close to the center of the polyE chain (E6CE9), the FRET efficiency increased upon 
adding polyK to a maximum value of ~0.4. At pH 7, in the absence of salt, the KD was found to 
be 1.65 × 10
-8 
M, table 2.2. With addition of NaCl, the KD decreased to 5.37 × 10
-8 
M (100 mM), 
and then further to 2.12 × 10
-7 
M (250 mM NaCl). The good agreement of the FRET data with 
the ITC data is shown in figure 2.5, with only a slight variance in the samples that used salt. One 
possible reason for this difference may be the concentration difference of polyE used in the 
experiments (50 nM for FRET vs 500 µM for ITC) since in the FRET experiments the 
concentration of the peptides approaches the KD value. Another possible reason is that for ITC 
the data were not accurately fit by a single-site binding model, suggesting more complex binding 
mechanisms could be present at the higher concentrations used in ITC. The data were fit using 
both the Morrison equation and Hill equation in order to determine the binding coefficients. 
Inspection of the fit curves and the χ
2
 values showed that the Hill equation fit the data much 
better, although the KD values obtained using both methods were very similar (figure 2.4). It was 
observed that the Hill coefficient was higher for the lower NaCl concentrations (n = 3 for 0 mM 
and n = 1.4 for 250 mM NaCl), indicating that the binding cooperativity increased as the ionic 
strength of the solution decreased. The most likely reason for this observation is that, at low ionic 
strength and high polyK/polyE ratio, the lack of charge screening between the homopolypeptides 
causes some degree of aggregation leading to multiple polyK’s binding to a single polyE, in 
agreement with ITC observations. However, the maximum FRET value observed in figure 2.4A 
35 
 
is the same 40% value independent of ionic strength, suggesting that, if aggregation does occur, 
the additional dyes are outside the maximum FRET distance range. 
 
Figure 2.4. FRET data fitted using Hill equation.  Labeled polyK/labeled polyE binding at pH 
7 with NaCl concentrations of 0mM (black), 100 mM (red) and 250 mM (blue) with different 










Table 2.2. FRET conditions and binding constants for polyE/polyK. 
Conditions Sample KD in M 
0 mM NaCl, pH 7 E6CE9/ K14CK 1.65 x 10 
-8
 +/- 1.7 x 10 
-9
 
100 mM NaCl, pH 7 E6CE9/ K14CK 5.37 x 10 
-8
 +/- 2.4 x 10 
-8
 
250 mM NaCl, pH 7  E6CE9/ K14CK 2.12 x 10 
-7
 +/- 8.3 x 10 
-8
 
0 mM NaCl, pH 7 E15C/ K14CK 2.53 x 10 
-7 
+/- 7.6 x 10 
-9
 
100 mM NaCl, pH 7 E15C/ K14CK 3.50 x 10 
-7
 +-/ 2.2 x 10 
-8
 
250 mM NaCl, pH 7 E15C/ K14CK 6.18 x 10 
-7





Figure 2.5. Comparison of KD measured using FRET (blue) and ITC (red). FRET data 
comes from the dye in the middle position on the polyE peptide. Error bars are from the error 
given in fitting. 
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When the dyes were both placed on the C-terminus of the charged homopolypeptides 
(figure 2.4B), two effects were discovered. First, the maximum FRET efficiency that was 
observed was much higher that when the donor dye was close to the center of the polyE chain 
(~0.9 vs. ~0.4). This indicates that the peptides are bound in a parallel arrangement bringing the 
donor and acceptor dyes into very close proximity. An antiparallel disposition of the 
homopolypeptides would have resulted in a lower FRET value that observed in figure 2.4A. 
Second, the KD values were reduced for the E15C samples compared to the E6CE9 samples at 
each given concentration of NaCl indicating that the binding was weaker when the dyes were 
forced to be close to each other. This also indicates that the preference for a parallel assembly 
must be so strong that the steric hindrance from the dyes was not able to force the peptides to 
bind in an anti-parallel arrangement.   
2.4.4. Far-UV CD spectroscopy of equimolar mixtures of polyE and polyK 
Far-UV CD spectroscopy is a powerful method to determine secondary structural 
information. However, the far-UV CD spectrum is an ensemble-averaged signal from all 
conformations in the sample and requires careful deconvolution to quantitatively estimate the 
constituent secondary structural elements 
43
. Nevertheless, changes in the average structure can 
be assessed by measuring the spectral changes at certain wavelengths (or ratios of wavelengths) 
upon binding or changing environmental parameters. The far-UV CD spectra of an equimolar 
mixture of polyE and polyK were acquired at pH values ranging from 1-14 (figure 2.6A, B). The 
CD spectra showed significant backbone disorder under all pH conditions.  The 222/208 nm ratio 
is higher for α-helices than random coils and a plot of mean residue ellipticity ratio (222 nm/208 
nm) versus pH (figure 2.6B) for the bound polyE/polyK did show some α-helical content at 
extreme pH values (pH 1 and pH 14).  Studies of long-chain polyK homopolypeptides 
31
 shows 
that, at high pH, they show α-helical secondary structure, while polyE is expected to be 
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disordered. At low pH, the converse is true; polyE forms a α-helix 
44
 and polyK is disordered. 
However, we find that, for 15-mer homopolypeptides, they are largely unstructured at all pH’s, 
although there is a minor contribution from α-helix structure at extreme pH, as evidenced from 
figure 2.6. 
 
Figure 2.6. CD spectra of polypeptides in water or TFE. A) Far-UV CD spectra of an 
equimolar mixture of polyK and polyE in water at pH 2 (black), pH 4 (blue), pH 6 (pink), pH 8 
(green), and pH 13 (cyan). B) Mean residue ellipticity ratio (222 nm/208 nm) as a function of 
pH. C) Far-UV CD spectra of the summation of the individual polyK and polyE spectra at pH 2 
(blue), pH 7 (black), and pH 13 (pink). D) Far-UV CD spectra of an equimolar mixture of polyK 
and polyE at pH 7 in TFE/H2O at 0% v/v (black), 12% v/v (blue), 30% v/v (pink), 45% v/v 
(purple), 75% v/v (green), and 90% v/v (cyan). E) Change in mean residue ellipticity at 195 nm 
versus concentration of TFE (v/v). F) Far-UV CD spectra of the summation of the individual 
polyK and polyE spectra at 0% v/v (black), 50% v/v (blue), 75% v/v (pink), and 90% v/v 




In order to follow the secondary structural changes of polyE and polyK upon binding, 
far-UV CD spectra of individual 15-mer polyE and polyK were separately measured at low, 
intermediate, and high pH and the summation of these individual spectra are shown in figure 
2.6C. Comparing figure 2.6A and 2.6C for CD, the ellipticity minima at 208 nm and 222 nm are 
slightly more defined in the summation of individual polyE and polyK spectra at extreme pH 
(figure 2.6C) than that observed for an equimolar mixture of the homopolypeptides at the same 
pH (figure 2.6A). These results suggest that, upon interaction of the homopolypeptides, the 
already low propensity for α-helix formation at low and high pH is reduced even further. 
 Electrostatic interactions are strengthened in solvents with low dielectric constants such 
as 2,2,2-trifluoethanol (TFE). In this context, the effect of dielectric of the medium was 
examined by treating an equimolar mixture of the polyE/polyK at pH 7.0 with different 
percentage concentrations of TFE v/v. Interestingly, although TFE is primarily considered to be 
an α-helicogenic solvent, addition of moderate TFE concentrations (~20% v/v) caused a 
transition of the bound polyE/polyK from primarily random coil to increased β-sheet structure 
(figure 2.6D). This is exemplified by the presence of a weak negative band centered near 216 nm 
and a strong positive band at 195 nm 
45
. To quantify the amount of β-sheet present in the 
equimolar polyE/polyK mixture the change in mean residue ellipticity at 195 nm was plotted as a 
function of TFE concentration (figure 2.6E). 
 As mentioned above, both polyE and polyK exist as random coils at pH 7. The spectra 
resulting from the summation of the individual spectra for polyE and polyK in increasing 
concentrations of TFE at pH 7 is shown in figure 2.6F. As expected, the spectra obtained by 
summation of the individual spectra for polyE and polyK reflect largely random coil structures 
below 75% v/v TFE concentrations and α-helical conformations above 75% v/v TFE. However, 
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when polyE and polyK were bound together, the CD spectra showed β-sheet rather than α-helical 
structure. Interestingly, much lower concentrations of TFE were required to induce a random coil 
to structured (β-sheet) transition in the bound homopolypeptides compared to the individual 
isolated homopolypeptides. A significant change in the mean residue ellipticity at 190 nm of the 
far-UV CD spectra of the equimolar polyE/polyK mixture was found between 0-20% v/v TFE. 
This much lower hydrophobicity threshold for interacting short-chains of polyE/polyK to form 
secondary structure may have significant implications in the binding-folding hypothesis of IDPs 
46
.  
2.4.5. TOCSY and NOESY NMR Spectroscopy 
Total Correlation Spectroscopy (TOCSY) is a nuclear magnetic resonance (NMR) 
spectroscopy technique used to correlate all the protons of a spin system. The resulting spectrum 
shows a specific pattern of crosspeaks for each amino acid. Nuclear Overhauser Enhancement 
Spectroscopy (NOESY) produces a crosspeak for each pair of nuclei that are coupled through 
space. The intensity of the NOESY crosspeaks depends on the inverse of the distance between 
the nuclei to the sixth power (1/r
6
). The combination of these two techniques provides atomic-
level information on the nature of interactions between the charged homopolypeptides.  
TOCSY and NOESY spectra were first acquired for the isolated homopolypeptides to 
unambiguously assign all the resonances. TOCSY and NOESY spectra for the polyE and polyK 
individually are shown in work done with our colloborator
47
, together with predicted chemical 
shifts. The TOCSY and NOESY spectra of the polyE/polyK mixture for two regions are shown 
in figures 2.7A and B. Three potential NOEs were observed. Two NOEs are indicated by the 
number “1” in figure 2.7A. Since the intensity of the NOE crosspeaks increases further 
downfield in the NOESY spectrum, the NOEs can be attributed to interactions between the 
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backbone N-H groups of the two charged homopolypeptides. For the NOE peak labeled as “2” in 
figure 2.7B, the intensity of the peak(s) increases further up field in the NOESY spectrum 
suggesting that the NOE represents the interaction between the H
ε
 of polyK and H
γ
 of polyE. 
This observation of NOEs shows that the polyE/polyK mixture primarily interacts via the 
electrostatic interactions between the oppositely charged side-chain groups of the two 
homopolypeptides, with only weak contributions from backbone H-bond interactions. These 
NMR results support and help explain the observations from the CD spectra that polyE and 
































Figure 2.7. TOCSY (blue) and NOESY (red) NMR spectra of polyE/polyK mixture at pH 7. 





2.4.6. Combining Structural and Thermodynamic Data 
The CD and NMR data provide some structural basis for the thermodynamic observation 
that the ΔH and ΔS are both positive upon binding at pH7 independent of the salt concentration, 
and that the binding is exothermic at the extremes of pH. The bond energy between the charged 
groups and the multiple solvent molecules or ions is relatively strong and this bond energy is not 
completely balanced by the newly-formed salt bridges between the K and E groups. However, 
the entropy strongly increases when solvent/ions that interact with the charged groups of polyK 
and polyE are released into the bulk providing the major driving force for the interaction. 
Clearly, the entropy decrease upon bringing together the two relatively small homopolypeptide 
chains together is more than made up for by this release of solvent/ions into the bulk. Naturally, 
as ionic strength increases, this argument holds since the only effect of the additional ions is to 
screen the interactions without affecting the overall structure. It seems that more solvent/ions are 
released when the chains bind in a parallel arrangement suggesting that the geometry of the 
chains play a role in the solvent/ion interactions. At the extremes of pH, where one of the 
homopolypeptides is uncharged, solvent molecules or ions interact less strongly with the polyK 
(at pH13) or polyE (at pH2). Bond energy is released by the ionization of the uncharged residues 
to form the salt bridge upon interaction. Although it was not quantified, one may expect that the 
entropy decrease from the interaction of the two chains is not as strongly balanced by the release 
of less solvent/ions into the bulk, leading to a more enthalpic-driven process. 
2.5. Conclusions 
We have presented a combined thermodynamic and structural study to better understand how 
oppositely-charged amino acids in short chain polypeptides interact. This interaction is measured 
when both polypeptides are charged or when one or both of them is/are made to be uncharged by 
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changing pH or solvent hydrophobicity. The main conclusions drawn from this combined study 
are as follows: 
1) When the ionization state of 15 amino acid homopolypeptides are both charged they are 
random coils and remain as random coils after their high-affinity interaction. The 
interaction is strongly entropy driven by releasing solvent/ions into the bulk. 
2) Upon changing the ionization state of 15-mers of polyE or polyK by pH, they maintain a 
great deal of random coil behavior both before and after interacting. There is a slightly 
increased propensity for individual polyE in low pH aqueous solvents and for individual 
poly-K in high pH aqueous solvents to form α-helical structures but this is reduced once 
they interact.  
3) There is an increased propensity for individual 15-mers of polyE and polyK to form α-
helical secondary structure in hydrophobic solvents such as TFE, but requires high 
concentrations (>75% v/v) to do so. After interaction, polyE and polyK form β-sheets 
under mildly hydrophobic conditions (<20% v/v TFE). 
4) Although they remain as random coils after binding, there is a strong preference for the 
homopolypeptide chains to bind in a parallel arrangement in aqueous solvents with the C-
termini and N-termini aligned with each other. 
The conclusions from this study helps expand our understanding of fundamental interactions 
between charged residues in highly acidic or basic regions of proteins on the scale of ~15 amino 
acid, which play important roles in regulation of protein interactions as well as underlie 
structure-function relationships in IDPs. Eventually, such knowledge may help us to determine 
the conditions that can result in both productive as well as harmful protein structures involving 
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The uses of fluorescent dyes are widespread in biolabeling experiments. There are many 
different types of fluorescent dyes available consisting of different structural classes, sizes and 
charges. We have investigated these varying effects of on the apparent binding affinity 
associated with charge-charge interactions. We have designed a system consisting of two 
homopolypeptides that bind primarily through electrostatic interactions with a preferred 
orientation that allows us to place the dyes so that they come very close to each other during 
binding. By attaching fluorescent dyes to these peptides, we are able to compare the binding 
affinity for various dye pairs through FRET to quantify which of the various dye properties are 
the most important to consider. Through this approach, we were able to show that the charge of 
the dye can be as important as the size or structure of the dye, even though this property is not 
usually considered as strongly by researchers during dye selection. By using dyes too close 
together, you can decrease the apparent binding affinity as well as the positive cooperativity of 




Fluorescent dyes are used in a wide range of biological and biophysical applications. One 
of the most common uses involve biolabeling studies to track protein movement
1-3
, visualize cell 
compartments
4, 5
, study protein folding
6-10
, and measure binding between ligands and proteins
11
. 
The most common structural motifs of fluorescent dyes used in biolabeling studies are 
coumarins, cyanines, xanthenes (fluorescein, eosin, and rhodamine), BODIPYs, oxazines and, 
more recently, carbopyronin, with each of the structural types having specific properties that 
determine how they can be used. Absorption and emission wavelength, molar absorptivity, 
quantum yield and photostability are the most important characteristics to determine suitability 
for a specific application. For example, it is known that solvent viscosity affects the quantum 
yield of cyanine dyes
12
 and this property has been employed as a method to measure binding 
between biomolecules at very close distances
13-15
. For FRET studies, the emission wavelength 
and the quantum yield of the donor, together with the absorption wavelength and molar 
absorptivity of the acceptor, determine the sensitive distance range probed during biomolecular 
interaction studies. However, other dye properties such as size, molecular structure and charge 
could also be important in probing such interactions, although they are usually less carefully 
considered during selection. In order for accurate conclusions to be drawn from experimental 
data, all such contributions from the fluorescent dyes should be examined and quantified.  
The use of fluorescent dyes attached to proteins allows one to measure binding 
coefficients between protein and ligand with high sensitivity. They are currently used to study 
DNA-ligand binding
16
, RNA targeting in cells
17
, and even heterogeneity of binding sites in 
stressed monoclonal antibody formulation
18
, among many others
19
. Currently in the literature, 
there is a very limited amount of papers that address the importance of dye charge and size 
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properties on experimental results. It has recently been shown that dye charge
20
 and certain 
functional groups on a dye
21
can have an effect on measured diffusion coefficients within a 
charged environment but little data exists as to how the charge affects biological binding, 
although some researchers have noted that using certain dyes can show different binding 
conformations depending on the protein/dye interaction under study
22
. Dyes can also cause steric 
hindrance when proteins are folding and force the protein to fold to an un-native conformation
23
. 
It has also been shown that dyes that are in close proximity can quench each other, and mislead 
researchers with faulty data
24
. In this study, we are particularly interested in quantifying the 
effect of the dye as it pertains to measuring the binding coefficient for interactions between 
charged residues, since such residues are important for long-range and short-range interactions in 
both structured proteins and intrinsically disordered proteins (IDPs). 
In order to determine specific effects related to the structure, size, and charge of a 
fluorescent dye on charge-charge interactions, we have developed a system to change each of 
these parameters in a well-controlled biomolecular template. By using two polypeptides that bind 
in a parallel arrangement regardless of dye position (chapter 2), we place the dyes so that they 
are forced to come into close proximity of each other. One peptide contains 15 lysines (PolyK) 
that bind to a partner with 15 glutamic acids (PolyE). This system is well-suited for measuring 
the effects of different dyes on binding because these two peptides interact primarily though 
electrostatic interactions (chapter 2). By employing FRET, we compare the effects of various dye 
pairs on the binding coefficients for this peptide template system by changing the dyes on each 
of the peptides. We have determined that the choice of dye has a strong effect on the measured 
dissociation constant, KD. If the bulky carbopyronin-based acceptor, Atto 633, which carries a +1 
charge, is used, the measured affinity is significantly lower than the actual affinity (independent 
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of whether a +1 or -1 charged donor is used) but if the small, neutral BODIPY is used as the 
donor, the bulkiness and charge effect of the Atto 633 is negated. On the other hand, if the large 
but zwitterionic xanthene-based Atto590 is used as the acceptor, the measured KD value is only 
slightly higher than the actual KD value, and is independent of the size or charge of the donor. 
The results of this study shows that both the size and charge of the dyes must be considered 
when making decisions about which dye pair to use for quantitative FRET studies in situations 
when the dyes will be close to each other. 
3.3. Materials and Methods 
3.3.1. Peptide Labeling  
Peptides with the sequence E15Cand K14CK were ordered from Genscript to enable site-
specific labeling using maleimide chemistry
25
. E15C was labeled with the donor dye (termed 
PolyE) and K14CK was labeled with the acceptor dye (termed PolyK). Labeling was carried out 
using a 5:1 ratio of dye to peptide in 10mM phosphate buffer at pH 7.2. The mixture of peptide 
and dye, protected from light, were allowed to react overnight. The unreacted free dye was 
separated out by dialysis using 2 kDa cut-off dialysis tubing (Spectrum Labs). The samples were 
dialyzed against 10mM phosphate buffer for 24-48 hours with the external buffer being refreshed 
every 2-6 hours. The labeling efficiency was verified by MALDI mass spectrometry (Bruker 
Ultraflex II TOF/TOF time-of-flight mass spectrometer equipped with a MALDI ion 
source)(Bruker Daltonik GmbH, Bremen, Germany). 
3.3.2. Fluorescence Resonance Energy Transfer (FRET) Spectroscopy 
  FRET measurements were performed on a PTI Quantamaster 40. The concentration of 
labeled PolyE was set at 5.0 × 10
-8





M. The sample was excited at either 470 nm (Alexa 488 and Bodipy) or 515 nm (Cy3) 
and emission spectra were collected from 480 nm to 750 nm (Alexa 488 and Bodipy) or 525 nm 
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to 750 nm (Cy3). The energy transfer efficiency was calculated at each concentration of 
acceptor-labeled peptide added by using the relative fluorescence intensity of the donor peak in 
the emission spectrum in the presence (FDA) and absence (FD) of the acceptor using equation 1
26
 
E= 1 – (FDA/FD).       (1) 




   E = (Emax*[PolyK]
n




)    (2) 
3.4. Results 
Figure 3.1 shows a schematic of the two labeled polypeptide chains as they bind. We 
showed in Chapter 2 that a parallel orientation is the favored interaction for the 
homopolypeptides between the charged side chains of glutamate and lysine. In this orientation, 
the donor and acceptor dyes are forced into close proximity of each other. The general structures 
of the dyes used in this study are shown in figure 3.2 and the source of each dye is given in table 
3.1. The cyanine dyes are large with two fused ring structures capping a linear conjugated chain, 
leading to a moderate amount of structural flexibility. The xanthene dyes contain four 6-
membered rings in a T-shape, together with several side groups on the rings and are much more 
rigid. The bodipy dye is much smaller than the others, containing a fused 6-membered and two 





Figure 3.1.Schematic of homopolypeptides binding. The Poly E and Poly K peptides align 
parallel to each other so that the effect of the close proximity of the dyes can be evaluated.  
 
 
Figure 3.2.General structures of the dyes used. A) Cy3 is bulky but somewhat flexible. B) 
BODIPY is rigid but very small. C) The xanthene dyes (Alexa Fluor 488 and Atto 590) are very 
bulky and rigid. D) Carbopyronin dyes are also bulky and rigid (Atto 633). 
 
Table 3.1.Full dye name, manufacturer, product number, and structural motif for all dyes 
used. 
Dye Name Company Product Number Structural Motif 
Alexa  Fluor 488 Molecular Probes A-10254 Xanthene 
Atto 590 Atto-Tec AD 50-41 Xanthene 
Atto 633 Atto-Tec AD 633-41 Carbopyronin 
Bodipy FL Molecular Probes B-10250 BODIPY 




Using FRET, we measured the binding affinities between the two homopolypeptides 
labeled with different dyes and under different conditions. We varied the NaCl concentration 
from 0 mM to 250 mM at pH 7.2. Figure 3.3 shows a decrease in binding affinity as the 
concentration of salt is increased, as expected for electrostatic interactions (chapter 2). A similar 
trend is seen in all dye-pairs studied. The KD values of all of the dye pairs that we examined are 
collated in Table 3.2. We have chosen dyes that we can pair together to investigate structural and 
size effects as well as charge effects. The salt concentration, Hill coefficients and maximum 


















Figure 3.3.FRET curves at different NaCl concentrations: 0 mM (blue), 100 mM (red) and 
250mM (purple). With increasing salt the slope of the curve decreases, consistent with the 









Table 3.2.Measured binding parameters for the different FRET dye pairs. Dyes carried 
either a +1 charge, -1 charge, were zwitterionic (+/-) or were neutral (0). 








Alexa 488/Atto 633 -1 +1 0 253 +/- 7.2 4.4 .86 
Alexa 488/Atto 633 -1 +1 100 350 +/- 22 2.0 .90 
Cy3/Atto 633 +1 +1 0 348 +/- 13 3.0 .93 
Cy3/Atto 633 +1 +1 100 578 +/- 24 1.3 .88 
Alexa 488/Atto 590 -1 +/- 0 103 +/- 15 5.0 .80 
Alexa 488/Atto 590 -1 +/- 100 48 +/- 5 2.2 .78 
Cy3/Atto 590 +1 +/- 0 94 +/- 5 4.2 .78 
Cy3/Atto 590 +1 +/- 100 65 +/- 4 2.6 .69 
Alexa 488/ Cy3 -1 +1 0 67 +/- 3.5 2.8 .74 
Alexa 488/ Cy3 -1 +1 100 35 +/- 1.4 2.0 .63 
Bodipy/ Atto 633 0 +1 0 49 +/- 2.3 2.9 .79 
Bodipy/ Atto 633 0 +1 100 90 +/- 5.3 3.1 .70 
Bodipy/ Atto 590 0 +/- 0 85 +/- 3.1 4.0 .84 
Bodipy/ Atto 590 0 +/- 100 75 +/- 3.9 4.2 .43 
 
In figure 3.4, the differences in KD values are plotted for each of the dye pairs at 0 mM 
and 100 mM NaCl. We also collected FRET data for all samples at 250 mM NaCl, but the much 
weaker binding between the polypeptides at this salt concentration precluded the data from being 
accurately fit (figure 3.3). Along the bottom axis, the data are sorted by the charge on the 
acceptor dye. The control KD value was obtained by ITC on unlabeled polypeptides and found to 
be 12.1 nM at 0 mM NaCl and 107 nM at 100 mM NaCl (chapter 2). In the case of the acceptor 
dye being a zwitterion, the measured KD values did not vary much between the differently 
charged donor dyes with KD = 103 nM (donor with -1 charge), KD = 94 nM (donor with +1 
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charge), and KD = 85 nM (neutral donor) at 0 mM NaCl. This is only slightly larger than the 
control value. In contrast, when an acceptor dye with a +1 charge was used, the KD values varied 
widely depending upon the charge of the donor. When the donor was neutral, the KD value was 
comparable to the control with KD = 49 nM at 0 mM NaCl. When the donor carried a +1 charge, 
KD=348 nM at 0 mM NaCl, while the donor carrying a -1 charge had KD=253 nM at 0 mM 
NaCl. When the concentration of NaCl was increased to 100 mM, the control KD decreased by 
about 1 order of magnitude compared to that at 0 mM NaCl. At 100 mM NaCl, the zwitterionic 
acceptor showed KD values that still did not depend on the charge on the donor, but did not 
become weaker at 100 mM NaCl, as the control did; KD = 65 nM for the donor with a +1 charge 
and KD = 48 nM for the donor with a -1 charge. However, when the +1 charged acceptor was 
used at 100 mM NaCl, the affinity did decrease compared to 0 mM, whether the donor carried a 
+1 (KD = 578 nM) or a -1 charge (350 nM), although the factor of the decrease was not as much 
as for the control. With the +1 charged acceptor and the neutral donor KD = 90 nM, effectively 
the same as the control. 
Due to the fact that the effect of the charge on the dye showed some unexpected 
behavior, such as oppositely-charged dyes not always leading to an increased affinity and that 
increasing the NaCl concentration did not always decrease the affinity, the effect of the dyes’ 
structure was also considered as a potential source for the effect. Depending on commercial 
availability, one can keep the charge on the acceptor as +1 but use different structural motifs. In 
the case of the -1 charged donor (the xanthene-based Alexa Fluor 488), we compared a +1 
charged acceptor with either the very similarly structured carbopyronin-based structure of Atto 
633 or the somewhat differently structured cyanine-based structure of Cy3. When the smaller, 
slightly more flexible cyanine dye was used as an acceptor the KD value at 0 mM NaCl was 67 
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nM compared to 235 nM for the larger, more rigid carbopyronin dye acceptor. At 100 mM NaCl, 
the KD values for the cyanine and carbopyronin acceptors were 35 nM and 350 nM, respectively, 

























 0 mM NaCl
 (+1) Donor
 (-1) Donor
  (0) Donor
 Control
Figure 3.4.KD values for dye pairs as a function of charge. The +1 charged acceptor was 
either the rigid Atto 633 or the slightly flexible Cy3 (denoted by **), whereas the +1 charged 




Figure 3.5 highlights the difference in the Hill coefficients based upon the charges on the 
dye pairs and the salt concentration. When the acceptor is zwitterionic, the Hill coefficient does 
not depend on the charge of the donor, the Hill coefficient stays high, between 4 and 5 for all 
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donors. The Hill coefficient was also similarly high for the -1/+1 D/A dye pair as well. When the 
acceptor has a +1 charge and the donor’s charge is either neutral or +1, the Hill coefficients are a 
little lower at ~3. Clearly, at 0 mM NaCl, the Hill coefficient is >1 for all dye pairs. In all but one 
case, the Hill coefficient decreases to ~2 as the concentration of salt increases to 100 mM. The 
dye pair where the donor is neutral and the acceptor has a +1 charge does not decrease at 100 


































0 mM NaCl 100 mM NaCl
Figure 3.5. Comparison of Hill coefficient for every dye pair with varying NaCl 




Finally, we quantify the maximum change in FRET (Emax) at the saturating concentration 
of acceptor-labeled PolyK for each of the dye pairs at 0 mM and 100 mM NaCl in figure 3.6. All 
of the Emax values at 0 mM NaCl are high (above 0.7), with most between 0.8 and 0.9. 
Interestingly, the D/A pair consisting of +1 xanthene/+1 xanthene shows the highest Emax value, 
while the D/A pair consisting of +1 xanthene/+1 cyanine shows the lowest Emax value. All the 
other dye pairs show effectively the same Emax value (between 0.80 and 0.85) independent of dye 
charge and structure. At 100 mM NaCl, the Emax values are still high (above 0.6), but show 






























Figure 3.6.Maximum FRET value for dye pairs. ** denotes when the +1 charged acceptor 




3.5. Discussion  
The central focus for this work was to determine if the choice of fluorescent dyes that are 
commonly used in FRET-based binding studies affects the results when electrostatic interactions 
are being probed. We purposely chose conditions in which the dyes are forced into close 
proximity of each other to determine the worst-case scenario. We have developed a 
homopolypeptide template system that forces this condition. It is clear from our results that, 
when the fluorescent labels come into close proximity of each other, they do have an effect on 
the measured KD values, although the effects are not as clear cut as one might anticipate. They 
depend on the size, charge, and structure of the dye label in varying degrees, which further varies 
with the ionic strength of the solution in which binding is studied. The control KD value for the 
binding of our peptides (PolyE + PolyK) was obtained by ITC, without using fluorescent labels, 
(Chapter 2) to enable absolute effects rather than relative effects to be quantified. At 0 mM NaCl, 
all of the KD values that were quantified using fluorescent labels showed weaker binding than the 
control although some dye combinations has only a marginal effect. The decrease in binding 
most likely arises from steric hindrance from the dyes interfering with the peptide interaction. 
The degree of the steric effect depends on both the size/rigidity of the dye as well as the charge. 
The peptides still bind very tightly (KD<100 nM in most cases) because there are still effectively 
15 charges on each peptide that attract each other. If the commonly used carbopyronin-based 
acceptor, Atto 633, which carries a +1 charge, is used, the measured affinity is significantly 
lower than the actual affinity (control value) when either the +1 charged Cy3 or the -1 charged 
Alexa Fluor 488 is used as the donor, with the +1/+1 dye combination being ~40% weaker than 
the +1/-1 dye combination, even though Cy3 is more flexible than Alexa Fluor 488. However, if 
the small, neutral BODIPY is used as the donor, the bulkiness and charge of the Atto 633 is 
negated, with the measured KD value being almost the same as the actual KD. On the other hand, 
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if the large, rigid but zwitterionic xanthene-based Atto590 is used as the acceptor, the measured 
KD value is only a little higher than the actual KD value, and is independent of the size or charge 
of the donor. For the situation when commercial availability allowed us to keep the charge on 
both the donor and acceptor the same (but complementary to each other) but change the dye 
structural motif, the bulkiness/rigidity effects can be studied. Comparing Alexa Fluor 488 (-
1)/Atto 633(+1) vs Alexa Fluor 488 (-1)/Cy3(+1), we can see that the Alexa Fluor 488/Cy3 pair 
was much closer to the actual KD value, being very similar to the cases in which the zwitterionic 
xanthene-based acceptor was used. Clearly the complementary dye charge is not enough to 
overcome the bulkiness of the carbopyronin-based Atto 633, whereas it is enough for the cyanine 
dye. It is possible that the flexibility of the cyanine dye allows it to be pushed into a position to 
allow the homopolypeptides to bind in a more natural way. 
When 100 mM NaCl is added to the buffer, the actual KD value for the homopolypeptide 
binding is increased, as expected for electrostatically-mediated interactions (chapter 2). 
However, only the situations in which the carbopyronin-based Atto 633 was used as the acceptor 
showed an increase in measured KD, and these were still much higher than the actual KD value at 
100 mM – except when BODIPY was used as the donor. In this case, BODIPY again allowed us 
to measure the actual KD value, as was the case at 0 mM NaCl. Clearly, BODIPY is an excellent 
choice of dye when dyes must be placed close to each other. Interestingly, when the zwitterionic 
Atto 590 or the cyanine Cy3 was used as the acceptor, no effect of increasing NaCl to 100 mM 
was observed. Since the KD value for these situations in 0 mM NaCl was very similar to the 
actual KD value at 100 mM, perhaps the increased salt concentration negated the remaining dye 
effect, although more experiments will be needed to confirm this possibility.  
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The Hill coefficient is a measure of positive interactions. For simple, sequential binding, 
the Hill coefficient (n) should be less than 2. In all cases at 0 mM NaCl, n>2. This suggests that 
the binding of the peptides is not a simple model in the sense that 2 peptides come together and 
bind. What is more likely happening is small clusters of peptides are forming. The hill 
coefficient values behave proportionally to the KD values, i.e. as the KD value shows weaker 
binding, the n value shows less positive cooperativity. These effects are from the size of the dye 
as well as the charge. When the bulky dye causes steric hindrance, it not only reduces the 
binding affinity but it also stops the peptides from forming the tightly bound small complexes. 
The charges act in the same way, the repealing charges won’t allow the peptides to bind as 
tightly as they would otherwise. 
Under the conditions of 100 mM NaCl, the n values are lower which is to be expected 
since the peptides interact through electrostatic interactions. In some cases, n<2, mainly when the 
KD value was very high. The same conditions apply here as in the 0 mM NaCl conditions, the 
dye is keeping the peptides from binding and forming the complexes that increase the Hill 
coefficient. When the BODIPY dye is used however, the n value stays very close to the same 
regardless of the salt concentration just like with the binding affinity. This neutral dye is has the 
minimal effect on the binding and stacking of the peptides.  
When analyzing the Emax values, a clear trend becomes apparent for both the 0 mM and 
the 100 mM NaCl experiments. In the peptide complexes that bind less tightly and have less 
positive cooperatively, the maximum FRET value is higher. Since the FRET is a measure of 
quenching, it can be presumed that the large complexes reduce the apparent quenching, by either 
peptides donating electrons to increase the quantum yield of the donor or by the 
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closeness/number of dyes present. Further experiments are needed to accurately ascertain which 
phenomenon is occurring.  
3.6. Summary and Conclusions 
With all of the fluorescent dye choices available, it is important to consider the system in 
which the dyes will be used. In FRET studies, the dyes are quiet often placed near a binding site 
in order to get high FRET values upon the binding of a ligand. We have shown that putting the 
dyes in an arrangement so that they come in very close contact with one another can be 
detrimental to the accuracy of the results. All parameters explored in this study, binding affinity 
and cooperativity, where affected by the nearness of the donor and acceptor dyes. In instances 
where the experimental design does not allow for options other than extremely close dye 
placements, it would be advisable to use small, neutral dyes to mitigate the effects the dyes 
cause, like decrease in binding and loss of positive cooperativity. At this point, the decrease in 
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IV. Insights on the Quenching of Some Fluorescent Dyes Commonly Used in Biolabeling by 
Charged Amino Acid Residues 
 
4.1. Abstract 
The use of fluorescent dyes in biolabeling studies has greatly increased in the past several years. 
One very popular method of measuring protein binding using fluorescent dyes is by FRET since 
it can be used to extract structural details due to its well-known distance dependence. We have 
determined that changes in the immediate environment of the dyes caused by binding of charged 
residues can affect the quantum yield of these dyes via quenching which will affect the extracted 
structural parameters. The effects of the charged environment are also determined by the charge 
of the dye used. If the fluorescent dyes must be used in the very near vicinity of charged 






Fluorescent dyes have been used for many years for a myriad of different applications 
from protein labeling and assays with DNA to individual proteins measured on a single molecule 
basis
1-4
. There is such a broad range of fluorescent dyes available and it is important to know 
which will best suit the needs of the system being probed. Several reviews have been published 
that describe various aspects of available fluorescent dyes and their uses
5-7
. Some of the most 
commonly used dyes include rhodamines, which have been used for labeling human cardiac 
tissue for use in imaging
8
, BODIPY’s, which have been used to probe lipids in microalgae
9
, and 
coumarins, fluoresceins, and oxazines that are used for fluoride sensing in cellular systems
10
. All 




Sometimes it is necessary to use fluorescent dyes in environments that are not the most 
ideal; e.g. near to highly charged regions of a protein or near to a binding site. Since most dyes 
have a charge themselves, the combination of these factors could pose a problem for obtaining 
accurate results. Others have started to investigate the effects of fluorescent dyes on results, from 
the charge of the dye interacting with glass surfaces
13
, to trying to distinguish between 
observable protein folding and dye photophysical induced data
14
. Dye effects have also been 
noted in studies of nucleic acids
15




Our lab has been particularly interested in studying charge-charge interactions in 
biomolecules (chapters 2 and 3), and we have been developing fluorescence-based assays to 
study the binding affinity and orientation between oppositely-charged homopolypeptides. We 




and the interaction. The results of that study concluded major differences in binding affinities 
due to the dyes’ interaction. In those studies, the reduction in the fluorescence intensity of a 
donor dye was used as a probe for interaction between oppositely-charged homopolypeptides. 
However, we did not expand upon which quenching mechanisms were responsible for the 
fluorescence decrease. The affinity can be determined without such knowledge, but in order to 
gain additional information from these experiments, such as interfluorophore distances that can 
be used to extract structural details, it is necessary to determine which mechanisms are 
responsible for quenching. For example, quenching by FRET to an acceptor fluorophore has a 
different distance dependence than by electron transfer to/from electron acceptor/donor residues. 
This study aims at addressing the relative contribution of FRET compared to these other 
quenching mechanisms. We found that that the near-vicinity of charged residues can affect the 
quantum yield of a dye, which depends upon the charge of the dye, the charge on the residue, as 
well as the distance between the two. In some measurements, the quantum yield of the dye will 
not affect the results of the study; however when using a technique such as FRET, quantifying 
the intensity of the dye in the environment that it is placed is very important. When using a 
method such as donor-quenching FRET, the intensity of the donors dye is used to measure the 
binding of the two partners, either protein-protein or protein-ligand. If the quantum yield (QY) of 
the dye changes at any time in the experiment, then the results can show either an increase in 
binding (for a decrease in QY) or a decrease in binding (increase in QY). We have developed a 
system that allows for direct comparisons of parameters changed in order to determine the exact 
effects of charges on fluorescent dye QY as well as how this changes apparent binding affinity. 
4.3. Materials and Methods 




Peptides with the sequence E15C, E6CE9 and K14CK were ordered from Genscript to 
enable site-specific labeling using maleimide chemistry. E6CE9 was labeled with the donor dye 
Alexa Fluor 488 (labeled polyE*). The E15C and K14CK were labeled with either a donor dye 
or acceptor dye (labeled polyE and polyK). Labeling was carried out using a 5:1 ratio of dye to 
peptide in 10 mM phosphate buffer at pH 7.2. The mixture of peptide and dye, protected from 
light, were allowed to react overnight. The unreacted free dye was separated out by dialysis 
using 2 kDa molecular weight cut-off dialysis tubing (Spectrum Labs). The samples were 
dialyzed against 10 mM phosphate buffer for 24-48 hours with the external buffer being 
refreshed every 2-6 hours. The samples were further cleaned up using 3 kDa spin columns 
(Millipore).  The labeling efficiency and separation of unreacted dye was verified by MALDI 
mass spectrometry (Bruker Ultraflex II TOF/TOF time-of-flight mass spectrometer equipped 
with a MALDI ion source) (BrukerDaltonik GmbH, Bremen, Germany). 
4.3.2. Fluorescence Spectroscopy 
 Fluorescence measurements that were carried out in in the absence of an acceptor dye 
were performed on a Perkin Elmer LS55. The concentration of labeled peptide was set at 1.0 × 
10
-6 
M. The unlabeled peptide concentration was 1.67 × 10
-6
 M to 1.65 × 10
-8
 M. The 
fluorescence measurements that did include acceptor dyes were performed on a PTI 
Quantamaster 40. The concentration of labeled polyE was set at 5.0 × 10
-8 
M. The concentration 
of labeled polyK varied from 5 × 10
-10
 M to 1.5 × 10
-6 
M. For all experiments the sample was 
excited at a wavelength depending upon the dye used (Table 4.1). Emission data was collected 
10 nm from the excitation wavelength up to 750 nm. The transfer/quenching efficiency, E, was 
calculated by using the relative fluorescence intensity of the donor at the maximum intensity in 
the presence (FDA) and absence (FD) of the oppositely charge polypeptide
17
 using: E= 1 – 
(FDA/FD). The KD value was calculated by fitting to the Hill
18




Table 4.1. Excitation and detection wavelengths as well as charges of dyes used. 
Donor Dye Excitation (nm) Detection (nm) Charge 
Alexa 488 470 480-750 -1 
Bodipy 470 480-750 0 (neutral) 
Cy3 515 525-750 +1 
Alexa 590 540 550-750 +/- (zwitterionic) 
Alexa 568 580 580-750 -1 
Atto 633 610 610-750 +1 
 
4.4. Results and Discussion 
We have investigated the FRET efficiency vs quenching by highly charged polypeptides 
on attached fluorescent dyes. The magnitude of difference between the two mechanisms depends 
greatly on the charge of the peptide, the charge of the dye, and the location of the dyes on the 
peptide. When a fluorescent label was placed on a positively charged homopolypeptide, the 
binding of a highly charged negative peptide significantly quenched the dye by 35-75%, figure 
4.1.  We believe this quenching is caused by the electrons being transferred from the excited 
state of the fluorophore to the polyK peptide (figure 4.2) with an electron being transferred from 
the polyE peptide back to the ground state of the fluorophore.  This process is much more 
efficient when the dye is placed on the polyK peptide vs placement on polyE. We believe this is 
due to the distance that the excited electron has to travel in order to be transferred. The shorter 
distance to the polyK means a quicker and more efficient transfer. When the dye is on the polyE, 
it is farther away from the electron acceptor. In the case of the donor dye being in the middle of 




directly on the polyK peptide. This drastic increase is likely due to the fact that there are now 
multiple residues in the near vicinity of the dye to accept the excited electrons.  










Alexa 568Alexa 590Atto 633
























Dye Quenched by polyK
Cy3BodipyAlexa 488 Alexa 488
Figure 4.1. Percent of fluorescence quenched by charged peptides. On left side, the dye is 
attached to polyE peptide and the addition of polyK decreases the signal. On the right side, the 
dye is attached to the polyK peptide and the addition of polyE decreases the signal. The * 






Figure 4.2.Schematic of peptide binding with relative quenching efficiency. A) The dye is 
attached to the polyK peptide. An electron is easily transferred from the dye to the positively 
charged peptide. PolyE gives up an electron in the ground state to the dye. B) The dye is attached 
in the middle of the polyE peptide. The bound polyK takes an electron from the dye; the polyE 
donates an electron back to the dye. Here the distance of travel is longer for the electron, but 
there are multiple pathways. C) PolyE has the dye attached at the C-terminus. The polyK takes 
an electron and the polyE donates one back. Here the distance is as long as in the middle 
example, but there is only one possible peptide to except the charge. 
 
Conjugating the Cy3 dye to the polyE peptide increases the quantum yield (figure 4.3) of 
the dye by 2.4 times from 68% (free in solution) to 100%. This increase in brightness may be the 
reason why the polyK does not appear to quench the dye, figure 4.1. In contrast, conjugation of 
the dye to the polyK reduces the quantum yield from 68% to 42%. The change in quantum yields 
are from the electron donating (polyE) or electron accepting (polyK) properties of the peptides 




to the maximum amount while the electron acceptor reduces the quantum yield by removing the 
excited electrons before they have time to fully relax back to the ground state through the normal 
fluorescence pathway. 













Figure 4.3.Quantum yield measurements for Cy3.The quantum yield of Cy3 was measured 
for dye alone, dye attached to polyK, and dye attached to polyE. 
 
The maximum transfer/quenching efficiency was examined to determine the relationship 
between the energy transfer and electron transfer mechanisms, figure 4.4. In all cases studied, the 
energy transfer results in a higher efficiency and greater reduction in donor fluorescence than 
when the electron transfer quenching only is present, which is as expected when there are 2 
processes occurring at the same time vs only a single quenching process. Since energy transfer 
(FRET) occurs at longer distances with weaker distance dependence than the electron transfer of 




the unlabeled polyK to labeled polyK. In the case where the donor dye was placed in the middle 
of the peptide instead of at the end, the energy transfer and electron transfer quenching both gave 
very similar results with the electron transfer only being slightly more efficient. The energy 
transfer in this situation is lower than when the dyes are both placed at the end because of the 
longer distance between the two dyes. The electron transfer is higher than the other samples 
where polyK is quenching the dye but lower than those where the polyE is the quencher (figure 
4.2. We expect this is due to the peptide orienting itself in such a way that the dye is close to the 
polyK peptide but not as close as it would be if the dye was conjugated to the peptide, figure 4.4. 
In the bottom of figure 4.4, the energy transfer as well as electron transfer graphs are shown for 
the Cy3 sample. The KD value is obtained by finding the midpoint of the curve. Both of these 
curves have very similar midpoints suggesting the KD value is the same regardless of the method 





































































Figure 4.4. The maximum transfer/quenching efficiency is compared between labeled and 
unlabeled samples sorted by charges. A) Labeled acceptor peptide in red, unlabeled acceptor 
peptide in black. In all labeled cases, the acceptor is Atto 633.B) Transfer/Quenching curves are 




 In figure 4.5, the measured binding constants are presented for each of the dye pairs depending 
upon the charge and whether or not the acceptor peptide has a dye. The KD values for labeled vs 
unlabeled polyK for each pair are equal or very close to equal for all pairs except when the -1 
charged dye is placed at the end of the peptide chain. When the dye was in the middle of the 
peptide the binding constant that was measured through energy transfer and electron transfer 
were both very close (KD = 54 nM +/- 24 nM  vs KD = 59 nM +-/ 24 nM, respectively) and  
comparable to that of the control (measured using ITC where neither peptide is labeled, KD = 12 
nM. When the +1 charged dye was used, the KD values for both labeled and unlabeled acceptor 
peptide were very close to each other, KD = 348 nM +/- 13 nM vs 368 nM +/- 42 nM, but were 
over an order of magnitude larger than the control, signifying a large effect from the donor dye. 
When the neutral dye was used, the unlabeled sample measured a slightly higher KD value than 
the labeled sample KD = 160 nM +/- 15 nM vs 90 nM +/- 6 nM, respectively.  It would appear 
that the neutral dye is somehow reducing the binding, either sterically or through electrostatics. 
These results are all different from the -1 charged dye pair that show a tighter binding or lower 
KD value when the acceptor dye is not present, KD = 67 nM +/- 10 nM vs 350 nM +/- 22 nM. 
This increase in KD may come from the acceptor dye as well as the donor dyes being repelled 
from their respective peptides and causing the peptides themselves to not be able to bind as they 




















Figure 4.5.  Comparison of the measured binding coefficients based upon the charge of the 
donor dye on polyE and whether or not the acceptor was labeled. Black: PolyK Peptide is 
unlabeled; Red: PolyK peptide is labeled with acceptor dye. The * represents the polyE peptide 
where the cysteine is in the middle of the chain instead of at the end. 
  
4.5. Conclusions 
Taking all of these results into consideration, it is clear that using fluorescent dyes around highly 
charged residues can severely effect results when reporting the total degree of quenching, rather 
than expanding on which quenching mechanism is responsible. In using FRET, it is common to 
use the decrease in donor fluorescence to measure binding. We determined that the effects of the 
charged environment on this parameter are unique to the dye as well as the environment. Each 




give a similar KD value, with the exception of the -1 charged dye. The amount of quenching 
through either FRET or electron transfer also varied by dye. It would appear as though the 
acceptor dye may not always be important for the measurement of binding affinity with 
fluorescence, as long as there is some sort of quencher available for the donor signal. In the case 
that a donor and acceptor dye are required, the donor dye should not be placed in a highly 
charged environment. If the options for dye placement are limited, then the best option is to use a 
neutral dye or to label your molecules in a manner so that the fluorescent dyes only come close 
enough to show high FRET but not close enough to interact. The distance needed will depend on 
the Forster distance for your chosen dye pair. It would also be advisable to not place your 
fluorescent label next to a charged amino acid since the quantum yield of the dye can be either 
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V. Purification, Labeling, and FRET with FGFR and FGF 
 
5.1. Abstract 
 Fibroblast growth factor receptor is involved in many important biological processes 
across different species as well as various tissue types. When FGFR goes unregulated, the result 
can be deadly. Almost all major cancers have a connection to unregulated FGFR. This protein is 
thought to have a self-regulatory process that reduces the ability for the receptor to bind to FGF, 
which is necessary for signaling. There are two competing models of self-regulation. We started 
looking at ways to either prove or disprove the two models. Our preliminary results show that the 





Fibroblast growth factors (FGF’s) are involved in numerous biological processes 
including wound healing and development
1-3
. FGF’s activate the fibroblast growth factor 
receptor (FGFR). There are more than 20 different FGF’s but only 4 FGFR’s
4
. These receptors 
are found in several different tissue types and the amount of each depends on the tissue it is in. 
FGFR participates in many different signaling processes
5
. The physical makeup contains 3 
immunoglobulin-like domains (D1-3) as well as a transmembrane region and cytoplasmic 
region
6
. All of the ligand binding occurs in the second (D2) and third (D3) domains with the D3 
domain only playing a small role. There is a disordered region (D1) and a flexible region (acid 
box, AB).  The AB connects the first and second regions (figure 5.1). This flexible region is 
termed the acid box because of the high percentage of acidic residues it contains. It is thought to 
participate in an auto-inhibition mechanism that involves the acid box and the ligand binding 
domain on D2
7, 8
. When FGFR goes unregulated, there are a plethora of diseases that can be 
obtained, including cancer
9-11
. FGFR must bind to both FGF and heparin in order for it to signal. 
There are two models proposed for the elf-regulation or auto-inhibition of FGFR. The first model 
predicts the AB will bind to the heparin binding site on the D2 domain
7
. This binding event is 
assumed to block FGF from binding and therefore inhibits signaling. We have devised 
experiments to determine if in fact the acid does bind to the D2 domain or if the other competing 
model is true. The second model hypothesizes that the AB binds to FGF instead
8
. In this model, 
when AB binds to FGF, the FGF binding site on D2 is blocked and keeps other FGF molecules 
from binding. Through ITC and FRET both, we were only able to measure very little to no 
binding between the acid box and the D2 domain of FGFR leading us to believe the secondary 





Figure 5.1. FGFR linear layout. FGFR contains 3 IG like domains (D1-3), an acid box region, 
a transmembrane region, and 2 tyrosine kinase domains. 
 
5.3. Materials and Methods 
5.3.1. Acid Box Peptide 
The acid box peptide was ordered from Genscript with the sequence of V-T-D-A-I-S-S-
G-D-D-E-D-D-T-D-G-A. This sequence aligns with residues 174 through 190 of FGFR2
12
.  
5.3.2. PCR, Expression, Purification of D2 and D2D3 domains of FGFR2 and FGF1 
The D2, D2D3 domains of FGFR2 as well as FGF1 was mutated to include cysteines at 
single locations using a QuikChange XL Site Directed Mutagenesis Kit from Stratagene. A his-
tag was added to the N-terminal end of the D2D3 domain using the mutagenesis kit as well. All 
primers used in PCR were ordered from IDT DNA Technologies. The thermocycler used for 
PCR was a master cycler gradient. Overexpression of the  D2, D2D3 domains as well as the 
FGF1 protein was performed as previously reported by Hung
13
 using BL-21DE3 PLys cells  
from E. coli (Novagen). After shaking at 37°C and 160 rpms until OD at 600 nm reached 0.6, 
IPTG (Isopropylthio-β-D-galactoside, 0.5 mM/L) was added to induce growth. Shaking and heat 
stayed constant until OD at 600 nm reached 1.5-2.0. The bacteria were then centrifuged at 6000 
rpms for 20 minutes. The pellet was then resuspended in a buffer containing 1xPBS (pH=7.2), 
1% v/v BME (β-mercaptoethanol), and 10 mM PMSF (phenylmethanesulfonylfloride).  The cells 
were then lysed using a sonicator in 1 sec pulses for 55 pulses. The sample was then centrifuged 




pellet is resuspended again in buffer containing 8 M urea and centrifuged at 10,000 rpms for 20 
minutes. Purification of D2, D2D3 proteins was performed using a nickel affinity column 
(Clontech), as described by Hung
13
. The protein was loaded onto the column after equilibration 
with 8 M urea. The protein was eluted with a gradient of imidazole with urea (20 mM to 500 mM 
imidazole, 8 M to 0 M urea). The D2, D2D3, and FGF proteins were also purified by heparin 
affinity chromatography (GE Healthcare).  The protein was loaded onto the column using a 
buffer containing 10 mM phosphate, pH 7.2. The proteins were eluted using a gradient of NaCl, 
from .2 M to 1.5 M. Purification was verified by SDS-PAGE (sodium dodecyl sulfate 
polyacrylamide gel electrophoresis), figures 5.2-5.8. Figure 5.2 displays the gel after purification 
by a heparin column. The protein of interest (D2 wild type) has a molecular weight of 14 kDa. 
The band on the gel appears slightly below the molecular weight marker of 17 kDa. In Figure 
5.3,  the D2 mutant 236C was purified also on a heparin column. The band on this gel is also 
slightly below the 17 kDa molecular weight marker. Figure 5.4 shows the gel after the 
purification of D2D3 wild type. Here the weight of the protein is 24.8 kDa. The band appears 
level with the 25 kDa marker. It should be noted that the molecular weight marker erroneously 
showed a double band for 25 kDa. Figure 5.5, 5.6, and 5.7, are all from the purification of the 
D2D3 protein. Each figure represents a different mutant however. For all cases, the band is 
around the 25 kDa marker. In figure 5.8, the gel shown is from the purification of FGF wild type. 







Figure 5.2. Gel of D2 wild type purification after the heparin column. The molecular weight 
of D2 is ~14 kDa. The band is slightly below the 17 kDa marker. 
 
 
Figure 5.3. Gel of D2 236C purification after the heparin column. Our protein is slightly 
below the marker for the 17 kDa control, which is where it should be. 
 
 
Figure 5.4. Gel of D2D3 wild type purification after the heparin column. The molecular 
weight of D2D3 is 24.8 kDa. The molecular weight marker that was used erroneously showed a 






Figure 5.5. Gel of D2D3 219/236C purification after the heparin column. The protein of 
interest produced a band  slightly below the 25 kDa molecular marker control band. Protein of 
interest = 24.8 kDa. 
 
 
Figure 5.6. Gel of D2D3 236/281C purification after the heparin column. Protein of interest 
molecular weight is 24.8 kDa. Band is present below 25 kDa marker. 
 
 
Figure 5.7. Gel of D2D3 222C purification after the heparin column. The molecular weight 
marker that was used erroneously showed a double band at 25 kDa. The protein of interest’s 







Figure 5.8. Gel of FGF wild type purification after the heparin column. The molecular 
weight of FGF is ~16 kDa. The band is almost even with the 17 kDa marker band. 
5.3.3. Fluorescent Labeling of acid box, D2, D2/D3 and FGF 
Acid box peptide was labeled with the donor dye Alexa Fluor 488. Labeling was carried 
out using a 5:1 ratio of dye to peptide in 10 mM phosphate buffer at pH 7.2. The mixture of 
peptide and dye, protected from light, were allowed to react overnight. The unreacted free dye 
was separated out by dialysis using 2 kDa molecular weight cut-off dialysis tubing (Spectrum 
Labs). The samples were dialyzed against 10 mM phosphate buffer for 24-48 hours with the 
external buffer being refreshed every 2-6 hours. The labeling efficiency was verified by MALDI 
mass spectrometry for the acid box; figure 5.9 (Bruker Ultraflex II TOF/TOF time-of-flight mass 
spectrometer equipped with a MALDI ion source (Bruker Daltonik GmbH, Bremen, Germany)). 
The proteins (D2, D2D3, FGF) were labeled using between 10:1 and 15:1 ratios of dye to protein 
in 10 mM phosphate buffer at pH 7.2. Tris (2-carboxyethyl) phosphine (TCEP) was added to the 
solution 30 minutes before the dye was introduced in order to reduce surface disulfide bonds. 
The mixtures were allowed to sit for 2 hours after the addition of dye, at room temperature and 
protected from light. The samples were then centrifuged in 3 kDa spin tubes (Millipore) to 






Figure 5.9. MALDI results from acid box labeling with Alexa488. The molecular weight of 
the acid box peptide is 1670.7 Da. The weight of the peptide + dye is 2368.7 Da. The peaks on 
the right side of the major peak presents the sample with sodium ions attached. 
 
5.3.5. Isothermal Calorimetry 
All ITC data was collected on a Microcal VP titration calorimeter (Northhampton, MA, 
USA). For D2 with acid box, the D2 concentration was 53 µM, the acid box was 499 µM. The 
injection volume was 6 µL with 30 injections. The buffer was 10 mM Phosphate, pH=7.2. The 
data was fit using Origin and the χ
2
 value was used to determine the best fit.  
5.3.6. Fluorescence Resonance Energy Transfer (FRET) Spectroscopy 
FRET measurements were made on a PTI Quantamaster 40. The concentration of labeled 
acid box was set at 5.0 × 10
-8 
M. The concentration of labeled FGF varied from 5.0 × 10
-10
 M to 
1.5 × 10
-6 
M. For D2 or D2D3 with FGF, the D2 (or D2D3) sample had the same concentration 




at 470 nm and emission data was collected from 480 nm to 750 nm. The transfer efficiency was 
calculated by using the relative fluorescence intensity of the donor at 516 nm in the presence 
(FDA) and absence (FD) of the acceptor
14
 using: E= 1 – (FDA/FD). The KD value was calculated by 




In order to measure the binding of the FGFR with FGF using FRET, we had to add a 
cysteine into the sequence of the protein to add a fluorescent label. The un-changed sequences 
for D2, D2D3, and FGF are shown in figures 5.10-5.12, respectively. By using site directed 
mutagenesis, we were able to make a mutation at amino acid 236 for D2. Some of the mutations 
that we tried to make but never could get to work were: 155C, 219C, and 281C. For the D2D3 
construct, the mutations that worked were: 219/236C (double), 236/281 (double), 222C, 241C, 
and 356C. The mutations that did not work were: 265C, 267C, 308C, 309C, and 358C. For FGF, 
the mutations that worked were 2C and 49C. After the mutations were made, some of the 
samples could not be purified to a high degree. These were samples D2D3 241C and D2D3 
356C. After receiving the sequence for the D2D3 protein, it was discovered that there was not a 
His-tag on the protein. We performed PCR in order to add a His-tag. The amino acid sequence 
for the D2D3 domains after the addition of the His-tag is shown in figure 5.13. 
 
Figure 5.10. Primary sequence for D2. This is the wild type sequence of D2. The his-tag is at 
the C-terminus of the protein. 
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Figure 5.11. Primary sequence for D2D3.  This is the original sequence for the D2D3 protein. 
Notice the lack of a his-tag. Without this tag, we could not purify the protein using affinity 
chromatography. 
 
Figure 5.12. Primary sequence for FGF. This sequence is the wild type sequence for FGF. We 
were able to purify FGF by using a heparin column alone, without the need to include a nickel 
column. 
 
Figure 5.13. Sequence for D2D3 after addition of His-tag. This is sequence of the D2D3 after 
the addition of a his-tag at the C-terminus. This sequence will be referred to as the wild type 
D2D3. 
 
Labeling the mutants that we made proved to be difficult. Before labeling, the absorbance 
of every protein was measured in order to determine the concentration, figure 5.14. After 
labeling, the samples were sent to the Arkansas Statewide Mass Spectrometry Facility for 
analysis. Figure 5.15 an example of the MALDI results after labeling. This MALDI spectrum 
Met N S N N K R A P Y W T N T E K M E K R L H A V P A A N T V K F R C P A G G N P 
M P T M R W L K N G K E F K Q E H R I G G Y K V R N Q H W S L I M E S V V P S D K 
G N Y T C V V E N E Y G S I N H T Y H L D V V E R S P H R P I L Q A G L P A N A S T 
V V G G D V E F V C K V Y S D A Q P H I Q W I K H V E K N G S K Y G P D G L P Y L 
K V L K H S G I N S S N A E V L A L F N V T E A D A G E Y I C K V S N Y I G Q A N Q 
S A W L T V L P K Q Q A P G R E Stop 
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M P T M R W L K N G K E F K Q E H R I G G Y K V R N Q H W S L I M E S V V P S D K 
G N Y T C V V E N E Y G S I N H T Y H L D V V E R S P H R P I L Q A G L P A N A S T 
V V G G D V E F V C K V Y S D A Q P H I Q W I K H V E K N G S K Y G P D G L P Y L 
K V L K H S G I N S S N A E V L A L F N V T E A D A G E Y I C K V S N Y I G Q A N Q 





shows that we had protein with several variations of numbers of dyes attached. Since the 
maximum that we could have had with the protein folded was 1, the rest are indicative of 
unfolded protein, which we also saw with the absorbance measurement in figure 5.16. We 
successfully labeled D2 236C with Alexa488, figure 5.17, even though a small amount of the 
sample did appear to have 2 dyes attached. When we were trying to label the D2D3 double 
mutants, we would add both of the dyes in at the same time. It did not matter where either of the 
dyes attached, only that both dyes were on each molecule. Several times we would end up with 
aggregated samples, figure 5.18. Other times we would have samples that only had a single dye 
attached, figure 5.19. We decided to start attaching one dye then the other, but this too yielded 
poor results. We obtained samples that had a low labeling efficiency; figure 5.20 for example, 
had a 5:1 ratio of protein of dye.  











Figure 5.14. Spectra of D2 236C before labeling.  The peak at 280 nm signifies the presence of 






Figure 5.15. MALDI results from D2 236C with Alexa488. The peak at 13150 represents the 
protein. All of the peaks with a higher M/Z ratio represent the protein with dye, +2 dye, +3 dye 
and so forth. Here the extra dye that are attached come from the protein most likely being 
















Figure 5.16. Spectra of D2 236C after labeling with Alexa488.  The peak at ~500 nm is from 






Figure 5.17. D2 236C with Alexa488. The peak at 13216 indicates the protein. The next 
downfield peak is for protein + dye, the last labeled peak is for protein +2 dyes. The extra dye is 
likely a result of unfolding of the protein, allowing the normally buried native cysteines to be 

















Figure 5.18. Absorbance of D2D3 219/236C. The sample contains both of the dyes, but it also 
appears to be aggregated by the peak that starts at 285 nm and does not come back down. 
 
















Figure 5.19. Absorbance of D2D3 236/281C. The sample contains one of the dyes, but not the 
other. Tt also appears to be aggregated by the peak that starts at 400 nm and does not come back 




















Figure 5.20. D2D3 236/281C with Cy3. The peak at ~550 nm donates the presence of Cy3 
while the peak at 280 nm indicates the presence of protein. 
 
The wild type FGF has 3 native cysteines. We determined that none of these cysteines 
were available for labeling by adding dye to the protein and then purifying the sample. In every 
case, the ratio of protein to dye was very high, anywhere from 37:1 to 20:1, figure 5.21. Because 
of this, we decided to introduce a cysteine at position 49. This mutant was successful and was 
easily purified. The labeling was also somewhat successful with a 7:1 ratio of protein to dye. 
This sample was not, however, refolded properly. After labeling, the sample was aggregated 
(figure 5.22). After the aggregates were dissolved, the protein would not bind to the D2D3 
















Figure 5.21. Absorbance spectrum of FGF with Cy5 dye.  The peak at ~650 nm is from the 
Cy5 dye while the peak at 280 nm is from protein.  
 













Figure 5.22. Absorbance spectrum of FGF-49C with Alexa488.  The presence of Alexa 488 is 























Figure 5.23. Ensemble FRET with FGF and FGFR. The scattered data points suggest no 
binding between the receptor and FGF. 
 
In our ITC experiments, D2 wild type was titrated with the acid box peptide. This 
experiment showed very weak to no binding, figure 5.24. We performed the same experiment 
using FRET to determine if the two were binding on a small scale. FRET also showed no 
binding, figure 5.25. We also decided to try ITC with the D2 wild type with a polypeptide that 
was designed to mimic the acid box peptide, but only contained glutamic acid. This peptide is 
termed PolyE and contains 15 amino acids, E15. For this experiment, there was binding between 





































Figure 5.24. ITC of D2 wild type with acid box peptide. The ITC results indicate that only a 

















Figure 5.25. FRET of D2 236C with acid box peptide. Green and purple represent two 
different trials. There was extremely weak binding in both. Data could not be fit to model 




































Figure 5.26. ITC of D2 wild type with PolyE peptide. ITC confirms that the polyE peptide 
does bind to the D2 domain, with relatively weak binding, KD = 37 mM. 
 
5.5. Discussion and Conclusion 
The auto-inhibition of FGFR is thought to occur by the acid box region of the receptor binding to 
the heparin binding site of the receptor
16
. In this model, the acid box binding on the heparin 
binding site is supposed to block heparin and the FGF from binding to the receptor
7
. Even 
though this is a popular model in the literature
7, 16
, our results from ITC (figure XX) as well as 




are preliminary and we hope future results will help to clear up the questions left at this point. 
Our results do however, correlate with Rutherford et al. who saw that the acid box has a higher 
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This body of work was aimed at determining if the auto-inhibition mechanism for FGFR that is 
popular in the literature is acruate
1
. This work was started by making a simplified homopolypeptide that 
would eventually morph into the actual amino acid sequence proposed to be involved in auto inhibition 
by FGFR. One model peptide was made to mimic the acid box – a 15-mer of glutamic acid (polyE). In the 
actual protein, the binding site on FGFR was thought to be a positively charged region in the D2 domain 
that binds to heparin. We used a 15-mer of polylysine (polyK) to mimic this binding site. For the 
polypepides that were used in FRET studies, a cysteine residue was added  to enable site-specific labeling 
using maleimide-functionalized dyes that react specifically with the terminal –SH group on cysteine. The 
binding of the peptides were characterized by ITC, CD, FRET, and NMR (chapter 2) and it was 
discovered that they bind in a parallel arrangement almost exclusively via long-range electrostatic 
interactions of the side-groups with little-to-no involvement of backbone hydrogen bonds. This leads to 
the polypeptides to remain as random coils after interacting. A parallel arrangement and electrostatic only 
interactions are somewhat counterintuitive, since longer versions of these peptides have been shown to 
form beta-sheets after interacting. Our data clearly shows that polypeptides of this length do not form 
beta-sheets in aqueous solution until the solvent polarity is decreased by adding trifluoroethanol. A recent 
molecular dynamics study
2
 showed that for 5-mers of polyE and polyK in dried layers, the difference in 
energy between parallel and anti-parallel arrangements was rather small, with the parallel arrangement 
resulting in more compact sheets. It is possible that, when the solvent is included and the length of the 
polypeptides is increased, such as in our studies, the balance of entropy and enthalpy shifts towards 
maintain a more entropically-favored random coil. In fact, our ITC results showed that both the DS and 
the DH of interaction is positive at neutral pH in both lower and higher ionic strength condition, verifying 
that the interaction is largely entropically driven. In the MD study
2
 a parallel arrangement was shown to 
result in a larger distance between  the peptides, which may allow the solvent to interact with the charged 
side groups enough to increase the entropy enough to balance out the enthalpy that would be gained by 




minimum length and charge composition of peptide that is needed to maintain this entropy balance before 
the formation of intra-peptide hydrogen bonds shifts the balance towards the formation of secondary 
structure. Indeed, answering such a question may prove to be extremely important in the area of amyloid 
formation that involve IDPs coming together to form ordered structures (often beta sheets) that  have been 




, Cystic Fibrosis and the human 
equivalent of Bovine Spongiform Encephalopathy (BSE), Creutzfeldt-Jakob disease (CJD)
4
. 
Through the course of the FRET studies with the polypeptides, we noticed that the exact 
quantification of our FRET data seemed to depend on the choice of dyes used. This forced us to start 
examining the role that fluorescent dyes played in the interaction of the charged polypeptides that we 
were using. In chapters 3 and 4, we were able to quantify the effects of the charges on the dyes 
themselves, as well as the effect of the charged amino acids on the dye fluorescence – both of which are 
very important for correct interpretation of FRET data. In chapter 3, we elucidated the fact that bulky, 
rigid dyes inhibited peptide binding and reduced the binding affinity but also decreased the cooperativity 
of binding, as evidenced by the change in the Hill coefficient extracted from our fits. Furthermore, dyes 
that had the same charges also reduced the KD value since they repelled each other, keeping the peptides 
apart. The structural flexibility of the dye also plays a major role, since this allows the dye to adopt 
conformations that interact less with other dyes. These effects are amplified when the dyes are forced into 
close proximity of each other, which was allowed in our system by the strong preference of the 
polypeptides to bind in a parallel arrangement. One important question to answer would be what the 
minimum distance is that the dyes must be placed apart from each other for them to have a negligible 
effect on the data. It is anticipated that, at larger distances, the charge of the dyes would become more 
important that their bulkiness and rigidity, since charge-charge interactions are longer range than the 
dimensions of the dye. Answering such questions is important when designing FRET assays to look at 




gone a long way towards this goal, since it shows which dye combinations work better than others when 
dyes must be placed relatively close together. 
Since our peptides were so highly charged, it was also necessary to uncover the effect of these 
charges on the quantum yield of our dyes when attached to, or brought into close proximity to, such 
residues (chapter 4). How the quantum yield of the dyes is affected by these highly-charged environments 
are very important to accurately measure FRET efficiencies which are used to extract inter-fluorophore 
separation and, in turn, structural information about the labeled biomolecules. After determining that the 
dye quantum yield was in fact influenced by the amino acid chain it was attached to, we monitored the 
change in quantum yield after the peptides bind to each other. We were able to establish a general 
mechanism for the quenching of the fluorescence of our dyes. This mechanism involves the transfer of an 
electron from the dye to the polyK peptide, which depends strongly on the distance between the dye and 
the amino acid chain as well as the number of quenching pathways (number of lysine residues) available 
within the short quenching distance. Since this quenching competes with FRET, lacking such knowledge 
of quenching will overestimate the FRET efficiency and may lead to inaccurate conclusions to be drawn 
regarding the structural details uncovered by FRET. The results of chapter 4 will help to correctly 
interpret FRET results when dyes are placed into close proximity of charged amino acids to enable more 
accurate inter-fluorophore distances to be extracted.   
Once we had quantified the how interacting charged residues affected each other’s structure and 
the roles that attached dyes played on this interaction, we then moved on to studying the more complex 
FGFR system. After the addition of a hexahistidine tag to the obtained FGFR plasmid through PCR 
(chapter 5), we were able obtain purified protein. FGFR contains 2 cysteines per domain (D2 and D3), but 
these residues are not available for labeling since they form disulfide bridges after folding. Because of 
this, we decided to add a cysteine into the sequence at various points in order to have several protein 
labeling options. Each mutation was made for a single protein variant, some containing single cysteines to 




mutations to enable intra-molecular FRET to be performed on FGFR. The single mutations enabled 
binding between FGFR and FGF or FGFR and the acid box peptide to be measured by FRET. After initial 
studies with ITC and FRET, the expected binding between FGFR and the acid box could not be verified, 
bringing into question one of the proposed mechanisms for FGFR auto-regulation
1
. Unfortunately, we 
have not been able to measure binding between FGFR and FGF, which is another proposed mechanism of 
FGFR autoregulation, due to the FGF being unstable after labeling and aggregation issues.  
Since one the proposed autoregulation mechanisms have been brought into doubt, future work 
should investigate alternative mechanisms. Such a project will include the following steps: 1) Producing 
new mutants of FGF that could potentially be more stable. After obtaining stable FGF, FRET and even 
single molecule FRET could be performed between FGFR and FGF. These studies should be able to 
determine if the acid box binds to FGF to determine if the alternative FGFR autoregulation mechanism is 
viable. If the binding between FGF and the acid box is present, NMR studies can also be conducted to 
determine where the binding is taking place on FGF. 2) The binding between FGF and the acid box 
should also be measured in the presence and absence of the D2D3 regions. This study will help to 
uncover whether the binding of FGF to the acid box is preferred over D2D3 or if this interaction is only a 
side effect. Just because the acid box will bind, does not mean that it is going to bind when other potential 
partners are available. 3) Measure the binding of peptides with all of the different FGFR acid box 
sequences since each receptor has a slightly different one. FGFR1 is the highest regulated with the longest 
acid box. The binding of these acid boxes could be compared to the regulation level for each one, after the 
binding mechanism is determined. 4) Determine the minimum number of charged amino acids that are 
required for the acid box to bind to its partner (either FGF or FGFR). It could be very helpful with future 
binding mechanisms if the minimal amount of charged residues is known. 5) Expand the 
homopolypeptide study by changing the amino acids one at a time to glycine and then measuring the 
binding between the polyE and polyK. Since there are many intrinsically disordered proteins in the body, 




one amino acid at a time, we could determine if small changes could force folding changes, aggregation, 
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